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 With the growing national dissemination of the electronic health record (EHR), 
there are expectations that the public will benefit from biomedical research and discovery 
enabled by electronic health data.  Clinical data are needed for many diseases and 
conditions to meet the demands of rapidly advancing genomic and proteomic research.  
Many biomedical research advancements require rapid access to clinical data as well as 
broad population coverage.  A fundamental issue in the secondary use of clinical data for 
scientific research is the identification of study cohorts of individuals with a disease or 
medical condition of interest.  The problem addressed in this work is the need for 
generalized, efficient methods to identify cohorts in the EHR for use in biomedical 
research. 
 To approach this problem, an associative classification framework was designed 
with the goal of accurate and rapid identification of cases for biomedical research:  
 (1) a set of exemplars for a given medical condition are presented to the   
 framework,  
 (2) a predictive rule set comprised of EHR attributes is generated by the   
 framework, and  
 (3) the rule set is applied to the EHR to identify additional patients that may have  
 the specified condition.   
  iv
Based on this functionality, the approach was termed the ‘cohort amplification’ 
framework. 
 The development and evaluation of the cohort amplification framework are the 
subject of this dissertation.  An overview of the framework design is presented.  
Improvements to some standard associative classification methods are described and 
validated.  A qualitative evaluation of predictive rules to identify diabetes cases and a 
study of the accuracy of identification of asthma cases in the EHR using framework-
generated prediction rules are reported.  The framework demonstrated accurate and 
reliable rules to identify diabetes and asthma cases in the EHR and contributed to 
























“Capture everything, we’ll sort it out later.” 
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 Although domain experts are vital to the oversight of any disease case 
identification algorithm, the translation of the clinical and health care encounter 
characteristics of a phenotype to EHR data specifications can be improved.  The cohort 
amplification framework may leverage the expert’s time by providing information on the 
EHR data which best distinguishes disease exemplars. 
 
Problem Statement 
 The problem addressed in this work is the need for generalized and computable 
methods to identify cohorts in the EHR for biomedical research.  With the growing 
national dissemination of the electronic health record (EHR), there are expectations for 
enhanced secondary use of the EHR for purposes of biomedical research.1, 2  Such 
functionality was explicitly defined as an objective in the developing national standards 
for meaningful use of the EHR.3, 4  Clinical data are needed for many different diseases 
and conditions to meet the demands of rapidly advancing genomic and proteomic 
research.5, 6  Other biomedical research to improve the general health status requires 
expeditious access to clinical data as well as general coverage of the population.7, 8  To 
use the electronic health record data for research purposes, the first step is often the 
identification of study cohorts of individuals with a disease or medical condition of 
  
2
interest.  Ideally, generalized criteria may be established for identification of cohorts in 
the EMR.   This enables researchers to design studies that might be applied across the 
population for broad attribution of results, pooling of subjects and equitable access.  The 
efficiency of biomedical research is improved when cohort identification logic can be 
shared and can be applied directly to the EHR. 
 BIOINFOMED, a study group funded by the European Commission (EC) 
addressed issues and challenges in correlating essential genotype information with 
expressed phenotype information.9,10  They reported that genomic and proteomic data 
must be integrated with electronic health record data, which can be used as expressed 
phenotype information.  Further, they reported that to obtain new knowledge, the 
phenotypes, genotypes and proteotypes of many patients from all over the world must be 
combined.  To make this possible, descriptions of the phenotypes must be standardized.  
They proposed structured clinician entry or computerized interpretation of EHR content, 
including free text, or a combination of methods. 
 
Current Solutions 
 Validated automated logic to identify disease-based cohorts in the medical record 
in the U.S. commonly uses International Classification of Diseases, Ninth Revision, 
Clinical Modification (ICD-9-CM) codes.  ICD morbidity codes have been recorded in 
hospital records in the U.S. since 1944.  They were originally collected for the systematic 
analysis of causes of morbidity and mortality.  This followed a long tradition of 
international disease classification efforts begun before 1785, now formalized under the 
World Health Organization as the International Classification of Diseases (ICD).11  ICD 
is intended as a classification for clinical, general epidemiological and many health 
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management purposes, while explicitly not intended for financial applications.12  In 1983, 
ICD-9-CM codes began to be used to determine reimbursement from healthcare payors in 
the inpatient setting in the United States.  Consequently, ICD codes in the U.S. were 
expanded and detail added in the International Classification of Diseases, Ninth Revision, 
Clinical Modification (ICD-9-CM).13  Subsequently, ICD-9-CM codes were used in the 
ambulatory setting to qualify the CPT procedure codes14 submitted for reimbursement.   
 ICD-9-CM based algorithms to identify disease-based cohorts have variable 
accuracy rates.15-21  Federal Health Insurance Portability and Accountability Act 
(HIPAA) guidelines for diagnostic coding have become complex, change several times 
per year, and require training for correct use.22  In addition, the ICD-9-CM codes in the 
EHR are typically bound to billing processes.  This leads to consistent recommendations 
that the use of ICD-9-CM codes to identify cohorts for biomedical research should be 
validated.17, 23-25   
 There is a general expectation that automated algorithms to identify disease-based 
cohorts can be improved by using additional EHR data rather than just ICD-9-CM codes 
alone.  Logic to identify cohorts from clinical and administrative data in the EHR are 
usually defined by domain experts and analysts based upon specification and analysis of 
attributes in the EHR and/or billing claims data for particular diseases.26-29  Such 
processes are often time-consuming for the experts.  Such a process to identify phenotype 
cohorts from the EHR was described by Starren:30 
 
 Define Phenotype → Translate Definition to Data →  Analyze Data → 




The expert’s role shifts to refinement of the machine-generated knowledge instead of 
specifying and analyzing data definitions: 
 
 Define Phenotype Exemplars 
 → Develop Rules Predictive of Exemplars of the Phenotype from EHR Data 
  →  Rule refinement  
  →  Identify Subjects →  Validate Algorithm → [repeat] 
 
 Natural language processing (NLP) of health care providers’ free-text 
documentation, a rich source of information in the EHR, is an active and promising area 
of research for purposes of disease case identification.31-35  The cohort amplification 
framework is complementary to NLP methods and processes in providing domain 
knowledge as well as opportunities to combine coded and free-text data.   
 Cases might also be identified if diseases or conditions of interest were 
documented by clinicians in the coded Problem List structure of the standard EHR.36-39 
However, at this time, notation in Problem Lists is not commonly integrated into the 
routine data/work flow of clinical practices.40, 41 
  
The Cohort Amplification Framework 
 A novel approach to identify cohorts in the EHR for biomedical research purposes 
was conceptualized, developed and evaluated.  Design of the cohort amplification 
framework was motivated by the need to find phenotype cohorts in the EHR for 
genomics research at the University of Utah.  The use case required the identification of 
many disease-related phenotypes of interest to researchers to support high-throughput 
familial clustering processes.42, 43  The design accommodated these needs with a set of 
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software components and processes that did not require reprogramming for a new disease 
or condition and required minimal domain expert input to generate classification rules for 
the disease.  This development work resulted in a collection of original Java components 
and Structured Query Language (SQL) database procedures. 
 The general use case for the design was:   
(1) A set of exemplars for a given medical condition are identified by a set of 
known rules, such as ICD-9-CM based rules. 
(2) A clinical profile (predictive rule set) is generated from the exemplars’ EHR 
data using the framework.  
(3) The predictive rule set is applied to the entire patient population in the EHR to 
identify additional patients that may have the specified condition.   
 
Exemplars 
 The FW takes two exemplar cohorts – referred to as cases and controls - as input.  
The framework generically exposes patterns in the EHR data that distinguish the 
exemplars with the condition of interest from exemplars without the condition.  Although 
the scope of cohort amplification supported by the framework includes any medical 
condition for which health care services are typically sought, the term ‘disease’ is usually 
used throughout this dissertation.  The condition of interest may be a syndrome or a 
subtype or subgroup of a disease.  Exemplars of a disease may be specified by a set of 
known rules, such as ICD-9-CM based rules or could be a researcher’s current list of 
known cases.  Those without the condition are referred to as ‘controls’.  The control 
exemplars may be negative for the condition of interest, or they may represent any 
contrasting cohort such as those with less severe disease status, if two subtypes of one 
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disease are compared.  The size and the representativeness of the exemplars will affect 
the quality of the prediction rules that are generated.  Given the large number of data 
elements used in the framework, both disease and control exemplar samples of at least 
1,000 are recommended for generation of reliable rules. 
 
EHR Data 
 The framework is distinguished by core candidate data attributes based on 
nationally required EHR observation categories.  The core data attributes were based on 
requirements specified for the certification of ambulatory medical records by the 
Certification Commission for Health Information Technology.44 This was the 
certification requirement for an EHR according to Centers for Medicare & Medicaid 
Services (CMS) when development of the framework commenced.  Subsequently, the 
Health Information Technology for  Economic and Clinical Health (HITECH) Act, which 
was part of the American Recovery and Reinvestment Act of 2009, authorized oversight 
for the national certification standards for EHRs.4  The new standards designed for 
‘meaningful use’ of the EHR also include the framework’s core data attributes3, 45.  The 
core attributes are typically populated in an EHR as a by-product of health care delivery 
and documentation processes. 
 There is no technical limitation to adding disease or site-specific content, but the 
focus of this research is standardized content for generalized application.  The list of 
candidate data attributes are easily modified in one component using SQL, by design.  
Data observation categories used in the framework for this research are: 
• Diagnosis and procedure codes (ICD-9-CM codes) 
• Provider and ambulatory clinic procedure codes (CPT codes) 14 
  
7
• Provider specialty (local codes) 
• Lab observations (CPT codes) 
• Lab observations with results coded as ‘Abnormal’ 
• Imaging procedures (CPT codes) 
• Medication list (FirstDataBank pharmacologic/chemical groups and ingredients)46 
• Age > 64 (true) 
• Female gender (true) 
 Support for attribute concept hierarchies was developed in order to address 
varying layers of granularity in native EHR data.  Attributes from the EHR observations 
may be mapped to concepts at higher levels of abstraction.  The framework uses a simple 
map of subsumption (‘Apple is a Fruit’) relations from an EHR attribute to a higher or 
subsuming concept.  This functionality was treated at a very basic level in order to 
generate reasonable rules, given the degree of data granularity encountered during 
development.  Semantic ontologies are the state-of-the-art knowledge engineering 
solutions to the variable granularity and relatedness of many concepts represented by 
native EHR data.  Such comprehensive ontologies are highly valued as informatics 
infrastructure for many applications.  They were out of the scope of the framework 
development reported.  The framework development did prove the need for a semantic 
ontology in order to derive useful association rules directly from the EHR. 
 Given the possible candidate attributes per the national certification standards, 
iterative and detailed analysis of the EHR data content available in the study setting was 
conducted.  Potential candidate data were analyzed for availability, consistency, quality 
and usefulness.  Analysis included descriptive statistics and interaction with data 
  
8
stewards and domain experts.  An approach to combine data across dimensions for 
presentation to the classification algorithm as a unified data set was challenging.  The 
resulting methods were generalizable to many different categories of EHR data but 
represented the data at a very high level of abstraction.  This enabled a core data set and 
methods that could accommodate multiple diseases or conditions and that could be used 
in any EHR setting. The design was modular and extensible to allow future 
enhancements. 
 
Predictive Rule Set 
 Initially, proven associative classification methods were used to generate the 
predictive rule sets.47-49  During development, rule sets were generated and evaluated 
repeatedly from different random samples.  Rule sets were not as reliable as desired.  
Innovative methods to improve the generality of rule sets were developed.  These 
improved the reliability.  The development and research reported in the subsequent 
chapters focuses on the generation and testing of predictive rules sets. 
   
Development/Research Setting 
  The cohort amplification framework was developed using data from a large, 
integrated health care delivery organization with a mature enterprise-wide, longitudinal 
EHR.  The Intermountain Healthcare Enterprise Data Warehouse (EDW) provided the 
EHR data for secondary use that enabled this work.  The EMR data of adult patients who 
visited an Intermountain Medical Group (IMG) central region Family Practice or Internal 
Medicine clinic at least once in 2005-2006 and at least once in 2007-2008 provided the 
target population for development and evaluation.  This provided 106,250 eligible 
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patients.  Adult primary care50 patients were chosen for the target population as Family 
Practice and Internal Medicine were visited by patients with a broad spectrum of 
conditions, and primary care was more frequently visited (~65% of adult patients in 
2008) than any other IMG specialty among patients with diabetes and asthma.  Primary 
care comprised 47% of all IMG adult ambulatory visits in 2008. 
 The required 2005-2006 visit was a ‘diagnosis period’ for the study.  The required 
2007-2008 visit was the ‘data mining period’ for the study.   Two-year periods were used 
as this was the duration for many validated ICD-9-CM based algorithms to identify 
diabetes or asthma.  A minimum of one visit in each of the study periods was required to 
provide a minimal amount of continuity of data.   This requirement did not appear to 
create a biased study population.  The average age and number of ambulatory visits/year 
were similar to the averages for Intermountain Healthcare ambulatory adult visitors. 
 Disease exemplars were identified from the coded Problem List during the 
diagnosis period.  Using cases with previously documented disease, the classification 
rules were trained on their data in 2007-2008, the data mining period.  Use of the 
Problem List has been integrated into the workflow in the central region IMG primary 
care setting.  About 65% of all eligible patients have a coded Problem List.  The Problem 
List was selected to identify disease exemplars because it includes both patients who 
present for treatment of the study disease, who are generally assigned an ICD-9-CM 
code, and those who present for other problems, in which case the study disease may not 
be assigned an ICD-9-CM code.  The goal was to predict disease status, regardless of 
whether treatment was sought for that disease in the surveyed time period. 
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 The disease-negative or control exemplars were generated from a random sample 
of all 106,250 eligible patients that had no evidence of the study disease by ICD-9-CM 
codes during the five-year period:  2003-2008 and no codes for the disease in the 
Problem List.  The controls were not matched to cases on other demographic or risk 
factors because the prediction rules need to distinguish the cases from among all other 
patients in the EHR.  Expected associations, such as a higher average age among diabetes 
cases, are absorbed into the associative classification rules-generation processes. 
            IRB approval was granted for this research from both the University of Utah and 
Intermountain Healthcare.  The cohort amplification framework requires no protected 
health information. 
 
Organization of the Manuscript 
            Associative classification was the approach used to develop prediction rules to 
identify new cases.  Associative classification is described in Chapter 2, with emphasis 
on specific aspects relevant to this work.  An overview of the functional processes of the 
cohort amplification framework and an evaluation of prediction rules generated for 
diabetes are presented in Chapter 3.  Rules generated to identify diabetes mellitus were 
compared qualitatively to EHR-based rules published from other settings.  The rules’ 
accuracy was evaluated on test data.  Chapter 3 was previously published.  The 
development of rules to identify asthma, including original enhancements to the standard 
associative classification methods, is described in Chapter 4.  Rule sets to identify 
asthma, generated by the both the standard and the improved methods, are compared on 
accuracy and generality.  A comparative study of the accuracy of framework-generated 
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rules to identify asthma cases in the EHR is reported in Chapter 5.  Chapter 6 contains a 
summary discussion of this research. 
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 Associative classification (AC) is a data mining approach that uses two basic 
strategies.  One is the deterministic and exhaustive generation of association rules 
between a predetermined outcome attribute and all other attributes, individually and 
combined, in a data set of training cases.  Associations are co-occurrences of attributes 
within the same case.  Exhaustive means that all associations are considered.  The other 
strategy is classification, a general machine-learning task to assign a group status to cases 
in the target population based on patterns generated from training data with known group 
membership.  Algorithms for classification – ‘classifiers’ -  may be generated by many 
diverse methods including decision trees, Bayesian networks, statistical models, neural 
networks, support vector machines, covering rules, associative classification, and 
others.1,2  In associative classification, the classifier is generated by the rigorous selection 
of a concise, general and accurate predictive subset of association rules from the 
exhaustive set of associations. 
 Data mining is one of the activities in the process of discovering knowledge from 
the large stores of data in databases.  Fayyad et al. defined knowledge discovery from 
databases (KDD) as the “nontrivial process of identifying valid, novel, potentially useful, 
and ultimately understandable patterns in data.”3  KDD has evolved from several fields 
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including machine learning, databases, statistics, artificial intelligence, high performance 
computing, and data visualization.  KDD has a unique goal within all of these, to find 
understandable patterns in the data that yield useful or interesting knowledge.  The steps 
in the KDD paradigm are: 
• Develop an understanding of the problem. 
• Develop an understanding of the data. 
• Prepare the data. 
• Apply data mining methods. 
• Evaluate and apply the discovered knowledge.  
 The data mining and evaluation stages may cycle back for a deeper understanding 
of the problem or the data.4  Practically, the process is re-entered at any of the steps and 
flows downward.  The steps are a ‘best practice’ model.   Each is critical to a worthwhile 
project, but knowledge engineers accomplish them with different emphasis and methods.   
KDD is not a scientific method.  It does not necessarily involve a specific hypothesis 
about the pattern-discovery outcomes, although it is purposed toward generating 
hypotheses for further scientific study.  Rather, KDD is a disciplined approach and a 
collection of proven methods to provide useful knowledge from existing data 
repositories.  
 Han and Kamber1 describe data mining as an evolution of the powerful databases 
that have become pervasive in the last decades.  Powerful computers and advanced 
services for data analysis, coupled with volumes of data collected and stored in databases, 
led to increased interest in machine learning and pattern recognition.  The data were 
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available for mining for golden nuggets of new knowledge and useful information.  They 
elaborated on the steps of KDD above: 
• Preparation of the data includes  
o Gathering data from multiple sources.  
o Removal of outliers and inconsistent data.  
o Attribute selection and transformation. 
o Input to the data mining programs. 
• Application of data mining methods includes 
o Selection of methods and algorithms. 
 More than one method may be applied on the same data. 
• Evaluation of the knowledge includes 
o Presentation of results to the users 
 Visualization techniques. 
 Knowledge representation techniques. 
 Witten and Frank2 described data mining as the search, discovery, and expression 
of patterns in the data.  The data come from databases and are usually large data sets.  
The processes to find patterns are automated or semiautomated with computers.  The 
patterns discovered should be meaningful or useful.  They should help us understand the 
data and/or make predictions from them.  They elaborated the KDD steps further: 
• Preparation of the data includes explicit handling of missing values in the training 
data.  Most data mining methods function under the assumption that missing 
values are random.  If missing values are correlated with other data, appropriate 
assumptions should be accommodated in the preprocessing.  Interestingly, they 
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give an example of missing medical tests as highly correlated with disease since 
doctors do not order them if they were not related.  They comment that the 
nonexistence of a test may be as predictive as the actual values.  This foreshadows 
results reported in this research. 
• Evaluation of the knowledge includes a broad array of methods.  Data mining 
algorithms and their specific result are a ‘theory’ over the training data, and thus 
evaluation may take a philosophical tone.  The entire KDD process must 
essentially be evaluated in context.  The normative method for evaluation of 
classifiers is validation of the results on repeated random samples of the training 
and test data with descriptive and statistical measures of the accuracy of results. 
 The selection of the training data is an important aspect of the evaluation of 
knowledge gained in KDD.  The larger the number of training cases, the more the 
reliability of results might be assumed.  However, generalization of the results to a wider 
population depends upon the cases that were used for training.  The selection of the 
training cases was noted as a critical step in machine learning.5  Selection of training data 
is often a pragmatic choice, given domain-specific issues in accessibility of data.  
Competitor businesses may not agree to pool their data so training may describe only one 
company’s experience.  In health care, training data may be limited to one provider 
organization due to data security and privacy concerns.  Even within one health care 
organization, there are stringent policies for protection of medical records such that the 
process of obtaining access to data is a significant additional process step.6 
 There are many categorizations of data mining methods.  They can be categorized 
by the purpose of the knowledge that is sought:  one purpose is classification.1  The 
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purpose of classification is to assign a ‘case’, the object to be classified, to a group, using 
the available data that describes the case.  Most classification data mining methods 
generate a ‘classifier’ from training data that has an explicit group ‘label’.  The group 
label is called a ‘class’.  This is called ‘supervised’ machine learning:  the classifier was 
trained on data where the class was previously assigned.  The purpose of the classifier is 
to ‘classify’ a new case, in which the class is not known from the data.  Classifiers use 
many different algorithms to perform classification.  They may be categorized by their 
approach to generating a classifier (Bayesian network, decision tree, neural network, and 
others), and further categorized on different algorithms employed to actually engage the 
data, render a classifier and apply the classifier to a new case.  Associative classification 
is one type of approach, which is implemented using various algorithms. 
 Associative classification (AC) may also be called classification by association, 
classification association rule mining, and other derivative terms.  It was also described 
as affinity analysis.7  The concept was first described by Bayardo8 as a “brute-force 
technique for mining classification rules from large data sets.”  He introduced the idea of 
association rules between a predetermined class attribute and all other attributes as 
classifiers.  It was called ‘brute force’ because of the exhaustive generation of 
associations.  However, Liu et al.9 are usually credited with the introduction of a more 
proper associative classification algorithm because they also used strategies to select the 
rules most likely to be predictive from all the association rules.  The exhaustive set of 
associations captures the patterns that are unique to the training data, known as ‘noise’, as 
well as those more generally representative of a larger target population.   
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 To generate classification rules from association rules, there must be a 
‘hypothesis’ for the selection of general rules over rules more specific to the training 
sample.  Classification rule discovery is an inductive task, predictive of the future, 
whereas association rule discovery is a deductive task, descriptive of the present.10  The 
main strengths of AC are the global view of all associations in the training data and the 
use of combined attributes for pattern discovery.  The main weakness is the generation of 
a large number of associations, which reflect the noise in the training data as well as the 
reliable associations. 
 Thabtah11 described the steps in associative classification as: 
(1) Discovery of associations among the training data attributes. 
(2) Generation of association rules between the class and other attributes. 
(3) Ranking and pruning of weak rules to form a classifier. 
(4) Prediction on test data and evaluation of the classifier’s accuracy. 
 In this chapter, an overview of association rule mining using the Apriori 
algorithm (steps 1 and 2 above) is presented.  Improved methods for constraining and 
pruning association rules to form useful classifiers are an ongoing topic of computer 
science research.  A novel pruning approach was developed in this research.  Therefore, 
the background on associative rule classifiers (steps 3 and 4 above) are covered in more 
detail.  Concept hierarchies in association rule mining and applications of associative 
classification in biomedical research are summarized. 
 A small example data set was created (Table 2.1) to clarify the technical 





Association Rule Mining 
 The foundational methodology of association rule mining (ARM) was first 
described by Agarwal et al.12  Their approach was seminal in that all associations were 
measured between the attributes in a data set, configuring each individual attribute as a 
rule consequent and all remaining attributes as a candidate for union in the rule 
antecedent: 
 
 Given the rule, ‘If A, then C’:  ‘A’ is the antecedent, and 
                                                              ‘C’ is the consequent. 
 
 The problem domain was retail sales, and the objective was to discover 
purchasing patterns and express them as association rules.  The rules were described as 
qualitative and deductive, as opposed to quantitative methods.  Quantitative methods 
generate predictive models using an inductive approach.  The methods vary greatly in 
their approaches to pattern finding, i.e., statistical regression analysis, Euclidean 
geometry, and Bayesian probabilities.  Generally, they sequentially process the training 
data to build and test a predictive pattern that best fits the data.  In distinction, ARM finds 
and reports all patterns found in the training data.  The ARM approach was targeted at an 
uncontrolled setting, where many interdependencies coexist in the data.  Domain 
knowledge was not a requirement to deduce the patterns, but may certainly be required to 
interpret and refine them for prediction. 
 The fundamentals of ARM were established.  The attributes in the model were 
called ‘items’, and the combination or association of items, ‘itemsets’.   The itemsets of 
interest were limited to those that occurred frequently in the training data set.  The user 
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would specify the minimum frequency of interest.  In the Disease Prediction data (Table 
2.1), if a minimum frequency of occurrence over all training cases was specified as 30%, 
then all of the attributes are ‘frequent’ items.  The frequent 2-item itemsets are ‘DrugA & 
TestC’, ‘DrugA & Class.PosDisease’, and ‘TestC & Class.PosDisease’.  There is only 
one frequent 3-item itemset:  ‘DrugA & TestC & Class.PosDisease’.  Once all of the 
frequent itemsets are found, the rules are formed.  In association mining, all frequent 
items in an itemset are permuted as the antecedents or consequents of rules.  The rule ‘If 
DrugA & TestC, then Class.PosDisease’ would be one of the rules generated.  All rules 
are then evaluated by a user-specified threshold for a measure of precision:  the 
likelihood that the rule consequent occurred, given that the rule antecedent occurred.  
Since the rule consequent occurred in 30% of the cases and the antecedent occurred in 
40%, the likelihood is 75%.  These are the basic pattern-discovery methods for 
association rule mining. 
 In a subsequent paper, the Apriori algorithm was described.13  The algorithm 
accomplished the same objectives for ARM as described but improved the computing 
efficiency.  ARM, without constraints and smart computer programming algorithms, is of 
exponential complexity in the number of attributes.  Much of the computer science 
literature on ARM deals with more efficient computing techniques.  The size of the 
solution space is significant for its computing requirements as well as the large number of 
association rules that may be generated.  Recall that one of the goals of data mining is 
understandable rules.  The authors of Apriori acknowledged that ‘application-dependent’ 
constraints are necessary features of an association rule discovery system. 
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 The Apriori ARM algorithm can be constrained to one specified attribute as the 
consequent of all rules.  In this case, all other attributes are candidates to form the rule 
antecedent.  For simplicity, assume that each attribute represents an item, and thus its 
value exists or it does not exist.  Only the attributes that exist are populated in the data.  
This was the representation of retail purchase data used in the presentation of the Apriori 
algorithm.  The Disease Prediction data (Table 2.1) also use this representation.  Assume 
that the desired minimum frequency of interest is ‘n’, and the desired precision of the rule 
given the antecedent is ‘m’.  Apriori scans the data set, counts all attribute occurrences, 
and enumerates those attributes that occur among n% of the records.  These are the 
frequent items.  The next step is to find frequent two-item itemsets.  Only frequent items 
can possibly combine to form frequent two-item itemsets.  The combined itemset cannot 
occur more frequently than any one of its members.  The two-item itemsets are combined 
into frequent three-item itemsets and this process repeats until there are no more frequent 
itemsets.  After all frequent itemsets have been enumerated, the candidate rules are 
formed from the one specified consequent attribute and all other members of its frequent 
itemsets as the antecedents.  All such frequent rules are then reduced to the set in which 
the precision of the rule is greater than or equal to ‘m’.  
 The publication of the Apriori algorithm concluded with the need for two 
extensions:   support for concept taxonomies and handling of discrete and continuous 
attributes.   Current applications of ARM generally support discrete attributes.  
Continuous attributes must be discretized.  The values of discrete attributes are 
considered as the items to be associated.  Other methods to perform association rule 
mining have been developed subsequent to its introduction with the Apriori algorithm.  
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They mainly address improvements to computing complexity but may also include 
alternate methods to evaluate the precision of rules.  ARM, by definition, is an exhaustive 
data scan for associations, given a frequent itemset threshold. 
 
Association Rule Classifiers 
 Associative classification is a specialization of association rule mining and one of 
the data mining approaches used to generate classifiers.  Freitas10 presented a thorough 
discussion of the additional requirements for association rules to be considered as 
classifiers.  The Disease Prediction data (Table 2.1) show an attribute ‘Class’ with the 
values ‘PosDisease’ and ‘NegDisease’.   AC must be constrained to the classifying 
attribute as the only rule consequent, in order to form rules predictive for the class.  
Another requirement is that the accuracy of the classification rules must be evaluated on 
test data.  The more important differences are theoretical.  The task of classification is 
inductive and nondeterministic.  A classification hypothesis is generated from training 
data, and its predictive success is estimated on test data.  Two major problems arise:  (1) 
Overfitting or underfitting the classification hypothesis to the training data is a main 
concern in classification.  ARM generates all rules, given constraints, over the training 
data.  (2) All classifiers have an inductive bias:  explicit or implicit criteria that influence 
the classifier to favor one hypothesis over another.  The methods and the configuration of 
the classifier form the bias for one hypothesis to be preferred over another.  Further, the 
bias is known to be domain-dependent:  the classification methods must interact with a 
specific data set to form a classifier.  ARM is deductive and deterministic.  Both 
problems are addressed in AC by various constraints, pruning methods (algorithmic 
identification and elimination of weaker rules), and use of class-specific definitions of 
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frequency for the selection of frequent itemsets.  AC cannot be constrained and pruned 
for overfitting/underfitting avoidance or inductive bias in a general set of methods to suit 
all domains and data sets.  However, such tuning can be customized for unique domains.  
The Pruning Methods section of this chapter presents general and domain-focused 
pruning methods used in health care data. 
 AC has been shown to perform as well as or better than decision trees, rule 
induction methods, and the naïve Bayes classifier on benchmark classification data sets.9, 
14-20
  The potential advantages of association classification over other classifiers are: 
• AC discovery is global:  all interesting association rules are discovered and then 
pruned to a more concise and general set. 
• Combinations (union) of attributes are used for pattern discovery.  
• AC was designed for application in noisy, highly dimensional and interdependent 
data such as the operational transactions of an enterprise. 
• Multiple hierarchical concept levels (taxonomies) can be mined for patterns in 
mixed or matched models. 
• Missing values can be configured to participate in the discovered associations or 
not, at the discretion of a domain expert.  If included, missing items participate in 
associations in the same way as a nonmissing item. 
• Generated rules are understandable to users. 




o Rules are amenable to interpretation as queries against the database mined, 
being “if-then” statements over arguments that represent attributes in the 
database. 
 AC has attracted researchers in the data mining and machine learning 
communities since it was first described in 1998.  There were 66 academic publications 
on ‘associative classification’ in Scopus21 for 2008-2009, which was higher than the 
previous two years at 42.  PubMed22 only listed 4 publications, all in recent years, but 
listed 83 publications on association mining since 2001.   The keyword “data mining” 
was added to the Medical Subject Headings (MeSH)23 in 2010, which suggests the 
growth of data mining research, in general, in the health care field. 
 
Interestingness Metrics 
 ‘Interestingness’ is a key data mining term. In classification, the hypothesis is 
guided and evaluated by a method’s interestingness metrics and their thresholds, if 
specified for the application.  Many statistical, mathematical and heuristic interestingness 
metrics have been used in data mining.  Interestingness has at least three interpretations.  
One is the objective thresholds and parameters that are used to configure a data mining 
algorithm.  Many, if not most, algorithms include user-specified parameters that bound 
the algorithm’s functionality.   For example, a statistical Type 1 error threshold is 
common in algorithms that use statistical comparisons over the mined data.  In ARM, the 
frequency and precision thresholds for rule generation are examples.  These are all 
considered ‘interestingness’ metrics because they constrain the algorithm’s results to 
those perceived as useful by the user.  A second interpretation is the criteria used to 
evaluate classification results.  In health care applications, the sensitivity and specificity 
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of a classifier may be used to compare two classifiers.  A third interpretation is the 
subjective concept of true interestingness of the knowledge generated.  These metrics or 
outcomes depend upon the goals of the consumers of the knowledge.24, 25  Data mining is 
an engineering task and not a scientific method.  Interestingness is an applied term and 
has been used somewhat ambiguously, although it is fundamentally an expression of the 
heuristic bias or merit of a data mining approach.  In the following review, objective 
interestingness metrics used in association rule mining and associative classification will 
be explored. 
 Geng and Hamilton26 surveyed interesting metrics for data mining and 
synthesized them into five objective criteria:  conciseness, generality/coverage, 
reliability, peculiarity, and diversity.  The first three are common to associative 
classification and germane to this research.  Concise rules are valuable because they are 
more understandable to domain experts who may subjectively evaluate and refine the 
classifier.27  Webb and Brain28 provided rigorous proof for the preference of a more 
general rule to a more specific one, given all other evidence was equal.  General rules and 
concise rules are intuitively related.  A more general rule covers more of the training 
cases than a less general rule, since that is what defines a ‘general’ rule.  Concise rules 
are the smallest set of rules that, together, achieve the best accuracy on test data.  
Therefore, assuming all other effects are equal, a set of more general rules should be a 
smaller or more concise set than a set of less general rules.  Reliability is the accuracy of 
a set of rules that form a classifier.  Measures of accuracy in AC commonly include 
‘confidence’, a term that was described above by the synonymous term ‘precision’ to 
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constrain and rank the rules.  There are also measures of the predictive accuracy of the 
classifier on test data.  
 
Measures of Generality 
 To generate prediction rules from the association rules, the most concise set of 
rules without loss of accuracy is desirable.  General rules are more comprehensive and 
cover more of the dataset.  Assuming general rules comprise the concise rule sets, the 
metrics for measuring generality will be addressed.  The most commonly used measure of 
generality in AC is the concept of ‘support’.  Support is a statistical measure of the 
frequency or likelihood of the occurrence of a rule.  The concept of frequent itemsets in 
the Apriori algorithm uses a minimum support threshold to define ‘frequent’.  As 
presented in the Association Rule Mining section, the minimum frequency of occurrence 
specified by the user forms a lower bound on the attributes and rules that will be 
considered ‘interesting’.  This is a constraint used to guide the generation of an 
associative classifier.  Assuming the rule antecedent is ‘A’ and the consequent is ‘C’, 
then 
 
 support (A → C)  =  support (A U C)1  =  count (A & C) / 
        count (training cases) 
  
 support (DrugB → Class.PosDisease) =  2 / 10 =  20% 
 (from Table 2.1) 
 
 Support is used to define the minimum threshold to allow large itemsets to 
participate in ARM, and is used in AC to rank rules.  Gu et al.29 introduced a 
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specialization of support for associative classification in the health care environment.  
When mining health care data to classify a specific disease, the nondiseased population is 
usually greater so class sizes are often unbalanced.  The common interestingness metrics 
fail to capture many interesting rules for the rarer class.  A specialization of support was 
defined to represent support for each class fairly, regardless of the sample sizes.  Such 
adjustments were recommended in order to apply association rules to prediction tasks10 
and were proven to be very effective in finding useful rules for rarer classes.30  The local 
support (LSUP) for each class was defined as the support for the rule for the class.  It also 
expresses the probability, based on the data, that the rule occurs when the class occurs.  
This metric is derived by dividing the support for the rule by the support for the class. 
 
 LSUP (Ci)  =  support (A → Ci) /  = Probability ((A U Ci) | Ci)    
   support (Ci) 
 
 LSUP (DrugB → Class.PosDisease) =  20% / 50% =   40% 
 (from Table 2.1) 
 
 When mining a database directly, as in the reported application, one can adjust for 
the differences in prevalence of the two classes by using the local support metric.  
However, most off-the-shelf association rule mining software packages use the support 
metric and not the local support metric.  In the case of a binary classifier, another way to 
approach the problem is to draw a balanced sample from the database so that the two 
classes are evenly distributed.  When sample sizes are large, there are no statistical 
restrictions to the use of balanced random samples from unequal reference population 
sizes in terms of representativeness.  A colorful analogy was drawn to illustrate this 
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concept:  a small spoonful of soup sampled from different sized pots will give the cook 
the same quality of information from each, provided the soups were stirred.31    
 With balanced sample sizes, the local support metric is roughly twice the support 
metric for each class of a binary classifier: 
 
 LSUP (Ci) =  support (A → Ci) / 0.5 
 
Thus, local support and support can be approximated from each other, given a binary 
classifier. 
 
Measures of Accuracy 
 Precision, or the likelihood that a rule consequent occurs given the rule antecedent 
occurs, was presented in the section on Association Rule Mining.  This measure of 
precision is commonly called ‘confidence’ in association rule mining and associative 
classification.  Confidence is used to define a user-specified minimum threshold to 
constrain the association rules that may be formed from the candidate frequent itemsets.  
After all frequent itemsets are found which satisfy the support interestingness metric, 
potential rules must satisfy the confidence or precision interestingness metric.  
Confidence is also used in the pruning processes as explained in the Pruning Methods 
section.  In AC, confidence is a measure of the likelihood (the probability based on the 
given data) of a particular class occurring as the rule consequent, given the rule 
antecedent.  This metric is derived by dividing the support for the rule by the support for 
the rule antecedent.  The rule consequents, by definition in AC, are assignments to one of 




 confidence (A → Ci)  =  support (A → Ci) / 
     support (A )           = Probability((A U Ci) | A ) 
 confidence (DrugB → Class.PosDisease) =  20% / 30% = 67% 
 (from Table 2.1) 
 
 Gu et al.29 also introduced a specialization of confidence for situations where 
class sizes are unbalanced.  Confidence is weakened for a rarer class by the ‘support (A)’ 
term in the denominator above.  If the larger class is represented 10:1 for a disease with 
10% prevalence, then ‘support (A)’ has 10:1 counts for the antecedent favoring the larger 
class of a binary classifier.  As the ratio of larger class to rarer class grows, it can be seen 
the denominator in the formula above grows and thus confidence for Ci decreases.  The 
exclusiveness (EXCL) metric was defined and proven to normalize the confidence metric 
for each class fairly.  It was defined for the binary classifier (Ci, Cj) as: 
 
 Exclusiveness (Ci) = LSUP (A → Ci) /  
    LSUP (A → Ci) + LSUP (A → Cj) 
  
 Just as most off-the-shelf association rule mining software packages use the 
support metric rather than local support, they use confidence and not exclusiveness.  In 
the case of the binary classifier and balanced class sizes, confidence and exclusiveness 
for a rule are equal.  Referring to the conversion formula from local support to support 
when sample sizes are balanced given above: 
 
   LSUP (Ci) =  support (A → Ci) / 0.5 
 Inversely:  support (A → Ci) =  (.5) LSUP (Ci) 
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 confidence (Ci) =  exclusiveness (Ci)  
                                     =  (.5) (LSUP (A → Ci) /  
                                            (.5) (LSUP (A → Ci) + (.5) LSUP (A → Cj) 
    =  support (A → Ci) / 
                                            support (A → Ci) + support (A → Cj) 
    =  support (A → Ci) / 
                                            support (A) 
 
 In the denominator of the final equation, the total support for A was distributed 
across the two possible rule consequents for A.  Added together, they comprise the total 
support for A.  Thus, exclusiveness and confidence can be approximated from each other, 
given a binary classifier. 
 Table 2.2 shows the magnitude of difference of the support versus local support 
and confidence versus exclusiveness metrics for a binary classifier of disease with 10% 
prevalence between a hypothetical balanced versus representative class sampling 
strategy.  The local support and exclusiveness are normalized and independent of the 
underlying prevalence in a representative sample.  The support and confidence are 
affected by the differences in prevalence in the representative sampling strategy.  The 
framework used balanced sample sizes to approximate the local support and 
exclusiveness from support and confidence metrics. 
 Measures of predictive accuracy in association classification are the same as those 
used for many other classifiers.  The results of classification are commonly viewed in a 
‘confusion matrix’,32 as described in Table 2.3.  Further, the confusion matrix may be 
repeated multiple times on separate random samples of the mined data, using different 
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cases for the training and test sets for each run.  With repeated samples, the accuracy 
metrics can be evaluated statistically.  This evaluation approach is called cross-
validation.2  The metrics used in this research to evaluate predictive accuracy are 
sensitivity and specificity because these are commonly used in the health care domain.  
More specifically, they were used to evaluate other classification algorithms that will be 
compared to AC classification in this research.  The sensitivity and specificity metrics are 
independent of the sample proportion.  Sensitivity is the proportion of the classified 
population determined to be positive by a reference standard and classified as positive. 
 
 Sensitivity = True Positives /  
                                  True Positives + False Negatives 
 
 Specificity is the proportion of the same classified population determined to be 
negative by the same reference standard and classified as negative. 
 
 Specificity = True Negatives / 
                                  True Negatives + False Positives 
 
        Sensitivity and specificity are inversely related in all but the two boundary 
examples:  all cases classified correctly or all incorrectly.  This is demonstrated in Table 
2.4.  The possible outcomes that occur for positive determinations by the binary classifier 
are ‘true positive’ (TP) or ‘false positive’ (FP).  The possible outcomes that occur for 
negative determinations by the binary classifier are ‘true negative’ (TN) or ‘false 
negative’ (FN).  The binary classifier must generate a positive or a negative 
determination for each case.  Assume that initially the sensitivity is zero, and the 
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specificity is 100%.  That is, no true positives have been identified and no true negatives 
have been misidentified.  As cases are classified as positive, a true positive case will 
increase the sensitivity, and a false positive will decrease the specificity.  At each 
positive classification determination, either the sensitivity or the specificity metric is 
affected in the opposite direction.  Once all cases are classified, the sensitivity will have 
increased from zero, and the specificity will have decreased from 100%.  The cumulative 
TP and FP proportions are reflected in receiver operator characteristic (ROC) curves, 
which permit visualization of the tradeoff between the two plotted on an X-Y axis.33  
Both a high sensitivity and a high specificity are desirable, in general.  However, 
depending upon the purpose of the application of a classifier and the user’s subjective 
interestingness preferences, a higher sensitivity or a higher specificity may be the 
preferred accuracy outcome. 
 
Pruning Methods 
  Since associative classification (AC) is a specialization of association rule mining 
(ARM), it inherits the limitations of ARM.  A large number of rules are generated since 
attributes are often highly correlated and, therefore, associated. The high correlation of 
attributes follows from direct mining of operational data, which is one of the fundamental 
objectives of ARM.  The global nature of rule discovery casts a net for all potential 
interesting patterns, but many redundant rules are discovered as well as rules that reflect 
idiosyncrasies of the training data (overfitting).  Therefore, it is necessary to apply 
‘pruning’ methods to eliminate (prune) redundant and weak class association rules in 
order to develop a general and accurate associative classifier.  Association rules have no 
basis for preference of one set of rules over another, other than the support and 
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confidence thresholds.  Multiple sets of rules might predict the class equally well on the 
training data.  Pruning methods address the rigorous ranking and selection of class-
constrained association rules in order to generate a concise, general and accurate 
classifier. 
 Thabtah34 provided a recent review of the main pruning approaches used in AC.  
The initial AC model, known as ‘classification by association’ (CBA),9 is still accepted 
and used as a benchmark for new AC methods.  CBA was based on the Apriori algorithm 
for rules discovery.  Subsequently a model, known as ‘classification based on multiple 
association rules’ (CMAR)20 was introduced.  CMAR is also a classic benchmark for AC 
methods.  CMAR uses a different strategy for rules discovery, accommodating some of 
its pruning methods earlier in that step.  Accuracy using CMAR was shown to be 
equivalent to CBA. 
 
CBA Pruning Methods 
 CBA uses the database coverage method.  More than one rule may cover the 
same case to be classified.  The rules discovered by association rule mining are ranked in 
order of confidence, then support.  Processing the rules in ranked order, the training cases 
that meet the rule are removed from further consideration by a subsequent rule.  If no 
case meets a rule, the rule is pruned.  This continues until all training cases have been 
covered or all rules were tested.  Cases left uncovered are assigned to the class with the 
highest frequency in the training data.   The database coverage method seeks the most 
accurate rules, by rank, and eliminates less accurate rules that cover the same cases. 
 An optional method is pessimistic error pruning, originally defined for decision 
trees.  The method assesses if the error rate for the majority class at a node in the tree is 
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less or equal to the classification error of its branch nodes.  If so, the branch node is 
pruned.  This method has not been implemented in AC as popularly as a similar method, 
redundancy pruning, described below.  They both compare the gain in accuracy from a 
parent node to a child node, and prune the child node if it does not improve accuracy.  A 
parent node is a more general rule than its child nodes and covers at least the same cases 
covered by the child node’s rule. 
 
CMAR Pruning Methods 
 CMAR uses the redundancy pruning method.  Redundancy pruning is 
implemented before the rules are ranked.  Multi-attribute rules that cover the same or 
fewer cases and do not improve the confidence of a more general rule, e.g., a subset of 
the multi-attribute rule, are redundant.  If rule ‘Ra’ was met, then rule ‘Ra U Rb’ is 
redundant unless its confidence is greater.  Rule ‘Ra U Rb’ (child rule) cannot have more 
support than ‘Ra’ (parent rule).  At most, it can have equal support.  The redundancy 
pruning method results in fewer, more general rules. 
 CMAR applies a chi-square test to prune rules before the rules are ranked.  If the 
rule antecedent and the rule consequent are not positively correlated, the rule is pruned.  
This pruning method must be provided in the data mining software or programmed to use 
with statistical tables for the significance of the chi-square scores. 
 CMAR also uses a variation on the database coverage method in CBA.  The rules 
are ranked by confidence and support.  The rules are tested for coverage in the training 
data in ranked order, as in CBA.  The difference is that a threshold on the number of 
times a case may be covered is set.  A covered case can be re-covered multiple times, 
generating several potential rules that may cover one case.  In the classification step, if all 
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rules that cover a new case agree on the class, the class is assigned.  If there is 
disagreement among the consequent among the set of classification rules that cover a new 
case, a normalized chi-squared test is used to assign the most accurate class.  This 
pruning step was meant to overcome the problem of favoring only one most confident 
rule.  Other slightly less or equally accurate rules may have higher support, and thus 
serve as better classifiers.  The overall confidence of the ranked rules and the user-
specified threshold on the number of rules that can cover each case will vary the effects 
on accuracy. 
 The pruning methods from CBA and CMAR are objective, general and effective 
methods.  Pruning methods may be mixed from among these and may also be combined 
with other approaches.35, 36  New pruning approaches may be compared with one or more 
of these basics.27, 34  Pruning may have a domain-specific rationale.  The two objectives 
are to remove redundant and misleading rules for the classification task at hand. 
 Pruning methods often include the ranking of rules.  Most AC pruning algorithms 
that depend upon rule ranking use confidence (descending), support (descending) and 
then cardinality (ascending).  The cardinality ranking supports rules that are more 
general.  Thabtah37 proposed and tested two additional rankings:  the frequency 
(descending) of the rule consequent, then precedence of the antecedent in the training 
data.  These slightly improved the average accuracy on highly dense datasets.  Rule 
preference affects the accuracy of the classifier.  Improvements in rule ranking was listed 
as one of the interesting research directions in associative classification.38 
 The purposes of pruning may be accomplished by constraints on the rules 
generation process.  Ordonez et al.36 introduced a constraint on the number of attributes 
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that may participate in the association rule antecedent of an associative classifier for heart 
disease.  After assessment of the impacts of the constraint at sizes from one to five, they 
used a limit of four attributes per rule antecedent in the rules discovery process for the 
classifier.  Because the high dimensionality in medical data results in many associations, 
this constraint disabled many redundant rules from forming in the first place.  It is 
straightforward to constrain the size of the large itemsets in the Apriori algorithm, as they 
are generated in cycles of ascending size.  This has the effect of global redundant rule 
pruning, given that additional attributes after the specified size do not add accuracy to the 
model.  This constraint also enables the Apriori algorithm to generate associations at 
lower support levels since the computing complexity is reduced to a small exponent.  
 
Concept Hierarchies 
 Concept hierarchies have been discussed in the ARM literature since its 
inception.13  With the objective of ARM to discover rules in large databases directly, the 
fine granularity of data comprising an enterprise’s operational transactions might obscure 
the interesting patterns.  For example, in the medical data domain, there could be many 
drug formulations in the same therapeutic class that might each exhibit very similar 
association patterns but may each be diluted by low support.  Assume that the drug 
formulations are stored in the training dataset, but they can be linked to a therapeutic 
class in a taxonomy.  If the associations with the therapeutic class rather than the 
formulations were exposed, there may be greater support for an interesting association at 
the therapeutic class level. 
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 Using the Disease Prediction data (Table 2.1), assume that DrugA and DrugB are 
both used to treat the disease and share the same therapeutic class.  Individually, the only 
interesting rule selected would be: 
 
 DrugA →  Class.PosDisease   confidence 4/5 = 80%, support 40% 
 
 A more interesting rule would be generated from the therapeutic class containing 
both: 
 
 DrugA or DrugB →  Class.PosDisease confidence 5/6 = 83%, support 50%  
 
 Operational data are often categorized into larger concepts for analysis and 
reports in an enterprise data warehouse.  A data element may belong to multiple 
categories.  In the drug ingredient example, there may be taxonomy of drug ingredients.  
A formulation may belong to a therapeutic class and have one or more ingredients.  The 
optimal concept level is generally unknown when the rules discovery task commences. 
 Han and Fu39, 40 described approaches to managing multiple concept levels in 
association rule mining.  Initially, Han emphasized user interaction to resolve the 
complex, domain-specific concept levels.  Subsequently, methods were developed to 
encode the concept levels into the transaction data.  The original methods were difficult 
to accomplish technically and supported only hierarchical concepts.  A transaction item 
could belong to a taxonomy of concepts; like ‘chocolate milk’ is ‘2% milk’ is ‘milk’.  
Methods for associating the concept levels ranged from associating across one level at a 
time to cross level associations.  There was thought toward varying support and 
confidence thresholds by level, and a pruning technique to recognize and disallow a rule 
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to contain an item and its conceptual ancestor (‘2% milk’ and ‘milk’).  The technology 
frontier has advanced considerably in the past decade.  Current research and development 
in data mining includes linking of the entire knowledge discovery lifecycle to domain-
specific ontologies.  Two recent projects describe association mining with semantic links 
to the Unified Medical Language System (UMLS) ontologies for data selection, pattern 
mining, data visualization and to provide some guidance normally provided by domain 
experts.41, 42  The linkage of databases to semantic networks opens up a completely new 
dimension to knowledge discovery. 
 The data mining software package used in this work was the Waikato 
Environment for Knowledge Analysis (WEKA) toolkit.2  It does not offer tools to 
accomplish even a simple concept taxonomy linkage as described above.  In the research 
reported in subsequent chapters, associative classification using multiple concept levels 
was implemented with a simple set of mappings from EHR-stored data to more general 
concepts for the purpose of aggregating very granular data.  Cross-level associations were 
allowed.  The more general concept was ranked higher and, therefore, less general 
concepts were pruned.  The research focus was the effect of aggregations on results and 
not the technologies used.  The data mining methods and linkages to accommodate the 
complex semantic relationships of stored health care data were beyond the scope of this 
research. 
 
Applications in Biomedical Research 
 Longitudinal electronic health records (EHR) are a perfect setting for association 
rule mining.  The longitudinal EHR covers both ambulatory and hospital care.  At this 
time, an EHR contains records of care for a particular healthcare delivery system only.  
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The EHR contains highly dimensional data.  There are many choices of disease labels, 
treatments and diagnostic test ‘items’ attached to a patient encounter.  The large set of 
possible ‘items’ are sparsely populated in each patient record.  The patient typically has a 
different set of ‘items’ at each encounter.  There is noise among these data.  The health 
care providers who assign the ‘items’ sometimes make intelligent guesses about 
diagnosis and treatment, and these may prove to be mistakes in terms of the true disease 
status.  There are also individual and group provider biases in the ‘item’ choices, such as 
medications prescribed for a particular indication.  The patient may attend another health 
care facility, so there may be an incomplete record of care.  However, there is a rich 
tapestry of associated ‘items’ that describe patterns across many patients’ encounters.  
Further, the ‘items’ reflect the decision making of providers, which form dimensions of 
interest.  For example, given incomplete individual patient data, the patterns may emerge 
for differences in treatments given by primary care practitioners versus treatments given 
by specialists.  Association rule mining describes multidimensional aggregate patterns, 
and, therefore, may provide new knowledge from sparsely populated, noisy and 
incomplete electronic health records. 
 Researchers have applied various association rule mining approaches to an 
assortment of problems using electronic health records (EHR) and secondary, anonymous 
patient data repositories.  McAullay et al.35 developed a framework for end users to mine 
the predictive attributes for adverse drug events directly from EHR data.  They used static 
and sequential association rule methods, developing a classification model focused on 
rare events.  Ordonez et al.36 developed methods for association mining over a 
cardiovascular clinical database to classify heart disease.  Li et al.43 developed an 
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association rule mining method based on frequent itemsets and relative risk to discover 
risk patterns in EHR data.  They applied the method to risk of hospital admission from 
the emergency department (ED) based on data routinely collected in the ED.  
Mahamaneerat et al.44 used ‘Domain Concept Mining’ to discover clinically meaningful 
associations in the 2005 Nationwide Inpatient Sample (n = 8,000,000 admissions).  
Elfangary and Atteya45 used association rules to discover novel patterns in an inpatient 
nephrology clinical data system.  They reported that the patterns were expressed in a 
manner that physicians could understand, and the mined rules were accepted by 
nephrology specialists.  Wright and Sittig46 used association rule mining to develop 
content for order sets in an ambulatory computerized physician order entry system.  Tai 
and Chiu47 applied association rule mining to study comorbidities of attention deficit 
disorder in the National Health Insurance Database of Taiwan.  They generated new 
knowledge on developmental delay and associations with progression to other psychiatric 
illnesses. 
 Associative classification has not been applied to the problem of generating rules 
to identify cohorts of patients with particular conditions from secondary EHR data.  
Secondary data are those collected for patient care purposes and subsequently used for 
other legal, ethical and beneficial purposes.48, 49  Although the task is to classify patients 
who have or have had a particular condition or disease from those who have not, this 
problem and solution space are unique from the problem of predicting disease for health 
care purposes.  Some conceptual differences are listed below: 
• Identifying cohorts with disease Predicting disease for care 
• QI, research, public health  Patient care decision support 
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• Data by-product of care processes Concurrent operational care data 
• Enterprise data warehouse  EHR transaction repository 
• As accurate as possible   Exacting accuracy required 
• Validation of cohort prediction  Validation of patient prediction  
• Accept available input data  Input data desired from workflow 
• Retrospective data view   Concurrent data view 
• Deductive knowledge value  Inductive knowledge value 
• Target user is not a clinician  Target user is a clinician 
 These differences are not absolute.  They are listed to point out distinctions in a 
primary patient care use case and a secondary data use case for identification of disease 
status.  The secondary data consumer must abide the quality of data that are available 
from the care processes that have already occurred, sometimes years earlier.  Association 
rule mining is well suited to the task.  The data mining method will expose the patterns 
that are there.  Associative classification will expose the patterns associated with a health 
condition or disease state, provided there are representative training cases where the 
disease status can be inferred.  If the disease statuses were accurately known for a large 
population of patients, one might question the need to develop a classifier.  That is not the 
case.  Patient records have not been consistently and accurately labeled for diseases 
treated, and less so for comorbidities.  The current research describes and evaluates an 
associative classification framework to identify cohorts of patients with particular 





Table 2.1  ‘Disease Prediction’ Data Set Example 
 
DrugA DrugB TestC Class
Case 1 Yes Yes PosDisease
Case 2 Yes Yes PosDisease
Case 3 Yes Yes PosDisease
Case 4 Yes Yes PosDisease










Table 2.2  Associative Classification Interestingness Metrics 
in Representative and Balanced Class Samples 
 
Rule + Rule -
Class 1 160 40 200
Class 2 90 1710 1800





Rule + Rule -
Class 1 800 200 1000
Class 2 50 950 1000





Hypothetical Disease with 10% Prevalence
Representative Sample Sizes
EXCL (Rule + -> Class 1)
LSUP (Rule + -> Class 1)
Confidence (Rule + -> Class 1)
EXCL
 (Rule + -> Class 1)
Balanced Sample Sizes
Support (Rule + -> Class 1)
Support (Rule + -> Class 1)
LSUP (Rule + -> Class 1)






































1 TP 1 12.5
2 FP 1 87.5
3 TN
4 TP 2 25.0
5 FN
6 TP 3 37.5
7 TN
8 TN
9 FP 2 75
10 TN
11 TP 4 50.0
12 TN
13 TP 5 62.5
14 FP 3 62.5




Positive (TP + FN) 8 Sensitivity
Cum TP 
Count / 8 75.0%
Reference 
Standard 
Negative (TN + FP) 8 Specificity
1 - (Cum FP 







1. Han J, Kamber M. Data mining:  Concepts and techniques: Morgan Kaufmann 
Publishers; 2001. 
2. Witten IH, Frank E. Data mining:  Practical machine learning tools and 
techniques with java implementations: Morgan Kaufmann Publishers; 2000. 
3. Fayyad U, Piatetsky-Shapiro G, Smyth P. From data mining to knowledge 
discovery: An overview.  Advances in knowledge discovery and data mining: AAAI/MIT 
Press; 1996. 
4. Fayyad U, Piatetsky-Shapiro G, Smyth P. From data mining to knowledge 
discovery in databases. AI Magazine. 1996(Fall):37-54. 
5. Mitchell TM. Machine learning. New York: McGraw-Hill; 1997. 
6. Cios KJ, Moore GW. Uniqueness of medical data mining. Artif Intell Med. 2002 
Sep-Oct;26(1-2):1-24. 
7. Shmueli G, Patel NR, Bruce PC. Data mining in excel:  Lecture notes and cases. 
Arlington: Resampling Stats, Inc.; 2005. 
8. Bayardo RJ. Brute-force mining of high-confidence classification rules.  Proc 3rd 
Int Conf on Knowledge Discovery & Data Mining (KDD-97) AAAI Press; 1997. p. 123-
6. 
9. Liu B, Hsu W, Ma Y. Integrating classification and association rule mining. In: 
Intelligence AAfA, editor. KDD-98; 1998; New York; 1998. 
10. Freitas AA. Understanding the crucial differences between classification and 
discovery of association rules: A position paper. SIGKDD Explor Newsl. 2000;2(1):65-9. 
11. Thabtah F. A review of associative classification mining. Knowledge Engineering 
Review. 2007 Mar;22(1):37-65. 
12. Agrawal R, Imielinski T, Swami A. Mining associations between sets of items in 
large databases.  ACM SIGMOD Int'l Conf on Management of Data. Washington D.C.; 
1993. 
13. Agrawal R, Srikant R. Fast algorithms for mining association rules in large 
databases.  Proceedings of the 20th International Conference on Very Large Data Bases: 
Morgan Kaufmann Publishers Inc.; 1994. 
14. Liu B, Ma Y, Wong C. Classification using association rules: Weaknesses and 
enhancements. In: Vipin Kumar ea, editor. Data mining for scientific applications; 2001. 
  
48
15. Mutter S, Hall M, Frank E. Using classification to evaluate the output of 
confidence-based association rule mining.  Ai 2004: Advances in artificial intelligence; 
2005. p. 538-49. 
16. Rodda S, Shashi M. An improved associative classifier.  Conference on 
Computational Intelligence and Multimedia Applications, 2007 International Conference 
on; 2007; 2007. p. 286-90. 
17. Rutkowski L, Tadeusiewicz R, Zadeh L, et al. An efficient association rule 
mining algorithm for classification.  Artificial intelligence and soft computing – icaisc 
2008: Springer Berlin / Heidelberg; 2008. p. 717-28. 
18. Thabtah FA, Cowling P, Yonghong P. Mmac: A new multi-class, multi-label 
associative classification approach.  Data Mining, 2004 ICDM '04 Fourth IEEE 
International Conference on; 2004; 2004. p. 217-24. 
19. Yin X, Han J. Cpar: Classification based on predictive association rules.  
Proceedings of the 2003 SIAM International Conference on Data Mining; 2003; San 
Francisco, CA; 2003. 
20. Li W, Han J, Pei J. Cmar: Accurate and efficient classification based on multiple 
class-association rules.  First IEEE International Conference on Data Mining (ICDM'01); 
2001; 2001. p. 369-76. 
21. About scopus.  2010  [cited Sept 21, 2010]; Available from: 
http://www.info.sciverse.com/scopus/about/ 
22. Pubmed.  2010  [cited; Available from: http://www.ncbi.nlm.nih.gov/pubmed/ 
23. Medical subject headings:  Entry terms and other cross-references.  2009 Sept 01, 
2009 [cited Oct 8, 2009]; Available from: http://www.nlm.nih.gov/mesh/intro_entry.html 
24. Ohsaki M, Abe H, Tsumoto S, Yokoi H, Yamaguchi T. Evaluation of rule 
interestingness measures in medical knowledge discovery in databases. Artificial 
Intelligence in Medicine. 2007;41(3):177-96. 
25. Silberschatz A, Tuzhilin A. What makes patterns interesting in knowledge 
discovery systems. Knowledge and Data Engineering, IEEE Transactions on. 
1996;8(6):970-4. 
26. Geng L, Hamilton HJ. Interestingness measures for data mining: A survey. ACM 
Comput Surv. 2006;38(3):9. 
27. Zaïane OR, Antonie M-L. On pruning and tuning rules for associative classifiers.  
Knowledge-based intelligent information and engineering systems; 2005. p. 966-73. 
28. Webb G, Brain D. Generality is predictive of prediction accuracy.  Data mining: 
Springer Berlin / Heidelberg; 2006. p. 1-13. 
  
49
29. Gu L, Li J, He H, Williams G, Hawkins S, Kelman C. Association rule discovery 
with unbalanced class distributions.  Ai 2003: Advances in artificial intelligence; 2003. p. 
221-32. 
30. Liu B, Hsu W, Ma Y. Mining association rules with multiple minimum supports.  
Proceedings of the fifth ACM SIGKDD international conference on Knowledge 
discovery and data mining. San Diego, California, United States: ACM; 1999. 
31. Tardanico R. Sample size and population size.   [cited Sept 12, 2010]; Available 
from: http://www.fiu.edu/~tardanic/size.pdf 
32. Provost FJ, Fawcett T, Kohavi R. The case against accuracy estimation for 
comparing induction algorithms.  Proceedings of the Fifteenth International Conference 
on Machine Learning: Morgan Kaufmann Publishers Inc.; 1998. 
33. Lasko TA, Bhagwat JG, Zou KH, Ohno-Machado L. The use of receiver 
operating characteristic curves in biomedical informatics. J Biomed Inform. 2005 
Oct;38(5):404-15. 
34. Thabtah F. Pruning techniques in associative classification: Survey and 
comparison. Journal of Digital Information Management. 2006;4:202-5. 
35. McAullay D, Williams G, Chen J, et al. A delivery framework for health data 
mining and analytics.  Proceedings of the Twenty-eighth Australasian conference on 
Computer Science - Volume 38. Newcastle, Australia: Australian Computer Society, Inc.; 
2005. 
36. Ordonez C, Ezquerra N, Santana CA. Constraining and summarizing association 
rules in medical data. Knowl Inf Syst. 2006;9(3):259-83. 
37. Thabtah F. Rule preference effect in associative classification mining. Journal of 
Information and Knowledge Management. 2006;5(1):13-20. 
38. Thabtah F. Challenges and interesting research directions in associative 
classification.  Sixth IEEE International Conference on Data Mining Workshops; 2006; 
2006. p. 785-92. 
39. Han J. Mining knowledge at multiple concept levels.  Proceedings of the fourth 
international conference on Information and knowledge management. Baltimore, 
Maryland, United States: ACM; 1995. 
40. Han J, Fu Y. Mining multiple-level association rules in large databases. 
Knowledge and Data Engineering, IEEE Transactions on. 1999;11(5):798-805. 
41. Kuo Y-T, Lonie A, Sonenberg L, Paizis K. Domain ontology driven data mining: 
A medical case study.  Proceedings of the 2007 international workshop on Domain driven 
data mining. San Jose, California: ACM; 2007. 
  
50
42. Svátek V, Rauch J, Ralbovský M. Ontology-enhanced association mining.  
Semantics, web and mining: Springer Berlin / Heidelberg; 2006. p. 163-79. 
43. Li J, Fu AW-c, Fahey P. Efficient discovery of risk patterns in medical data. 
Artificial Intelligence in Medicine. 2009;45(1):77-89. 
44. Mahamaneerat WK, Kobayashi T, Green JM. Domain-concept mining on the 
2005 nationwide inpatient sample data.  American Medical Informatics Association 
(AMIA) 2007 Annual Symposium, Knowledge Discovery and Data Mining Working 
Group (KDDM-WG); 2007; 2007. 
45. Elfangary L, Atteya WA. Mining medical databases using proposed incremental 
association rules algorithm (pia).  Proceedings of the Second International Conference on 
Digital Society: IEEE Computer Society; 2008. 
46. Wright A, Sittig DF. Automated development of order sets and corollary orders 
by data mining in an ambulatory computerized physician order entry system. AMIA 
Annu Symp Proc. 2006:819-23. 
47. Tai Y-M, Chiu H-W. Comorbidity study of adhd: Applying association rule 
mining (arm) to national health insurance database of taiwan. International Journal of 
Medical Informatics. 2009;78(12):e75-e83. 
48. Hersh WR. Adding value to the electronic health record through secondary use of 
data for quality assurance, research, and surveillance. Am J Manag Care. 2007 Jun;13(6 
Part 1):277-8. 
49. Safran C, Bloomrosen M, Hammond WE, et al. Toward a national framework for 
the secondary use of health data: An american medical informatics association white 











OVERVIEW OF THE COHORT AMPLIFICATION FRAMEWORK 
 
 AND EVALUATION OF PREDICTION RULES 
 










Reprinted from Proceedings of the American Medical Informatics 
Association Annual Symposium Proceedings, 2010.  Welch SR, 
Huff SM. Cohort amplification: An associative classification 
framework for identification of disease cohorts in the electronic 
health record.  Pages 862-866, ©2010, with permission from the 
American Medical Informatics Association. 
  
52
Cohort Amplification:  An Associative Classification Framework 
for Identification of Disease Cohorts in the Electronic Health 
Record 
 
Susan Rea Welch, MS, BSN, Stanley M. Huff, MD 
University of Utah, Intermountain Healthcare, Salt Lake City, UT 
 
Abstract 
With the growing national dissemination of the electronic health record (EHR), there are 
expectations that algorithms to identify disease-based cohorts for health services research will be 
deployable across health care organizations.  Toward that goal, a novel associative classification 
framework was designed to generate prediction rules to identify cases similar to the exemplar 
cases on which it was trained.  It processes exemplars for any medical condition without 
modification.  The framework is distinguished by core candidate data attributes based on common 
EHR observation categories, application of associative classification methods to cull disease-
specific attributes and predictive rules from the core attributes, and support for attribute concept 
hierarchies to manage the various layers of granularity in native EHR data.  The framework 




Functionality to identify disease-based cohorts has been explicitly defined as an objective in the 
developing national standards for meaningful use of the EHR.3  A framework (FW) was developed 
to generate prediction rules to identify research cohorts for various medical conditions using a 
generalized approach from coded EHR content.  The general use case for the design was:   (1) a 
set of exemplars for a given medical condition are identified, (2) a clinical profile (predictive rule 
set) is generated from the exemplars’ EHR data using the FW, and (3) the rules are applied to the 
entire patient population in the EHR to identify additional patients with the specified condition.  
Since the objective was to identify new cases based on data patterns of known cases, it was called 
a ‘cohort amplification’ framework. 
 
Background 
Algorithms have been developed from EHR data, including standard diagnosis and procedure 
codes, to identify disease cohorts for research.  A typical process was described by Starren:30  (1) 
define a cohort by clinical characteristics, (2) translate to EHR data, (3) analyze the data, (4) 
identify subjects, (5) validate the algorithm, and (6) iterate.  The FW may leverage the experts’ 
time by providing information on EHR data content and distinguishing features among cohort 
exemplars early in the process: (1) define characteristics, (2) identify exemplars of the cohort, (3) 
expose EHR data availability and predictive value for exemplars, and then formulate an algorithm, 
validate and iterate. 
 
Natural language processing (NLP) of free-text provider documentation, a rich source of 
information in the EHR, is an active and promising area of research for purposes of disease case 
identification 31.  The FW complements NLP efforts with domain knowledge and an opportunity 
to combine evidence. 
 
The FW was developed from data in a large, integrated health care delivery organization with a 
mature enterprise-wide, longitudinal EHR.  The Intermountain Healthcare Enterprise Data 
Warehouse provided the EHR data for secondary use that enabled development.  Three diseases 
were selected for the focus of development:  diabetes mellitus (DM), asthma, and clinical 
depression.  These diseases are significant health problems and have established health care 
guidelines, which provided a source of domain knowledge for development and testing of the FW.  
IRB approval was granted for this research from both the University of Utah and Intermountain 





1.  Description of the Cohort Amplification Framework 
 
The cohort amplification FW was designed to meet the use case depicted above the dashed line in 
Figure 1.  The processes and their implementation artifacts are depicted below the dashed line.  
Each process is described below: 
 
EHR attribute selection 
The basis of the candidate attribute categories was coded attributes defined by a national EHR 
certification organization as content requirements for ambulatory EHRs.44  There were no 
technical limitations to adding disease or site- specific content, but the FW focus was standardized 
content for generalized application.  Data used in the FW included diagnosis and procedure codes, 
provider and ambulatory clinic procedure codes,  clinical lab tests performed, lab tests coded as 
abnormal, imaging procedures performed, medications in the EHR Medication List, and other 
demographic and encounter features.  Exemplar patient attributes were populated once for each 
unique coded observation that occurred.  Continuous observations were discretized as binary 
attributes:  ‘age > 47 = true.’  There was no treatment for missing values.  Attributes represented 
data that were populated in the EHR.  An implicit attribute was the ‘class’ designation, which was 
generated from the exemplar lists, e.g., case or control.  A class attribute is a fundamental of 
associative classification, serving as the consequent of all rules. 
 
 
Figure 1 – Cohort Amplification Framework 
 
Attributes from the EHR observations were mapped to concepts at higher levels of abstraction.  
The FW used a simple map of ‘is-a’ relations from an EHR attribute to a list of abstract concepts.  
When an attribute was instanced, all mapped concepts were also instanced.  For example, URINE 
MICROALBUMIN and SERUM ALBUMIN were mapped to ALBUMIN.  The FW considered 
all three  as attributes to generate prediction rules from cross-level associations.86  
 
The initial step in associative classification was applied to all EHR and derived attributes.  A Java 
component developed for the FW was used.  A data set containing attributes at a specified 
frequency of occurrence among disease cases was transferred to the data mining software. 
 
Associative classification mining in the Waikato Environment for Knowledge Analysis  
The next step was to use the Waikato Environment for Knowledge Analysis (WEKA) toolkit for 
association mining.52  The Apriori algorithm constrained to the class attribute consequent was 
used.47  Thabtah60 described the steps in associative classification (AC) as discovery of 
associations among the training attributes, generation of rules associating other attributes with the 
class attribute,  ranking and pruning rules to form a predictive rule set, and testing it on unseen 
data.  WEKA Apriori was used for discovery and generation of the class association rules.  The 
single attribute rules input from the EHR were selected according to standard AC interestingness 
metrics specialized for this application.  In AC, the most common measures of interestingness are 






































‘support’ – the frequency of a rule in the data set – and ‘confidence’ – the likelihood of a 
particular class occurring, given the rule.  These metrics only describe the training data from 
which they were generated.  
 
In the FW, ‘local support’ for the disease class (LSUP), rather than support, was used.  This is the 
frequency of the rule (a single attribute or a combination) among the disease case exemplars.  For 
example, if 82% of DM exemplars have the attribute ‘Abnormal_HbA1c’, the LSUP is 82.  A 
specialization of confidence was used:  ‘exclusiveness.’  Exclusiveness of the disease class 
(EXCL) is its local support divided by the sum of both the disease and the control classes’ local 
support.  For example, if the LSUP of ‘Abnormal_HbA1c’ among control exemplars is 0.6, then 
the EXCL is 82/(82+0.6) = 99 (expressed as a percentage).76 
 
The WEKA Apriori association program was modified to use a variable threshold on the 
maximum number of attributes combined in a rule antecedent.  Exponential combinations of 
attributes can accrue, if unbounded.83  Antecedents with three or more attributes did not contribute 
to predictive accuracy in testing of configuration choices for the DM data presented.  Constraining 
the number of attributes per rule also enabled the Apriori algorithm to run in the available 
processor memory (16 Gb.) at the desired minimum support threshold (2.5%). 
 
Prune weak rules 
The next step was to prune weak rules.  Association rules must be pruned (generalized) for 
prediction purposes.  The most concise set of rules without loss of accuracy is desirable.59  Three 
pruning methods were implemented in Java components using the interesting attribute sets and 
metrics from WEKA.  Redundant rule pruning48 and database coverage pruning49 were performed.  
An additional pruning method was developed to improve the generality of rules in this EHR data 
setting.  The methods are not detailed in this overview.  Functionally, configuration choices in the 
new pruning method were designed for specification on an application basis:  the desired 
specificity threshold for the prediction rule set, the minimal number of pruning data set cases each 
rule must cover, and the minimum positive predictive value (PPV) of each rule on pruning set 
cases.  PPV is the proportion of case coverage by the rule to the total coverage by the rule. 
  
The new pruning method was also designed to manage multiple concept levels in the candidate 
rules.  Higher order concept levels were preferred, given two concept levels for the same attribute.  
For example, a drug observation represented by an ingredient, ‘Insulin’, was mapped to a drug 
class, ‘Antihyperglycemic.’  If both presented as single attributes in the final pruning process, 
‘Insulin’ was pruned. 
 
The final pruned rule set was executed against a separate test database.  The sensitivity and 
specificity of the prediction rule set on test data was calculated. 
 
Domain knowledge 
The final pruned rules should be examined for concordance with domain knowledge.  Evaluation 
of the machine-generated knowledge and iteration of the process steps are cornerstones of 
knowledge discovery from data mining.54  
 
2.  Qualitative Evaluation of the Cohort Amplification Framework 
 
Three parameters for successful prediction rules were defined for this evaluation:  (1) accuracy on 
test data, (2) consistency with domain knowledge, and (3) conciseness and generality.  Training 
and test data were sampled from the EHR data of adult patients who visited an Intermountain 
Medical Group (IMG) Family Practice (FP) or Internal Medicine (IM) clinic in Salt Lake County 
at least once in 2005-2006 and at least once in 2007-2008.  DM case exemplars were a random 
sample of those with DM coded in the Problem List prior to 2007.  Control exemplars (CTLs) 
were a random sample of those with no Problem List DM codes prior to 2009 and no ICD-9-CM 
DM codes assigned during 2004-2008.  The sample sizes were 4,001 DM cases and 4,019 CTLs.  




Four data sets for evaluation were generated in two random, stratified, two-fold cross-validation 
runs using the Knowledge Flow interface in WEKA.  Each of the 8,020 patient records was 
randomly assigned in each of two runs.  Each fold numbered ~2000 records for training data, 
~1000 for pruning data, and ~1000 for test data.  EHR attributes were selected if they had a 
frequency of at least 5% among cases:  there were 472 qualified attributes for the study 
population.  The main 3-digit ICD-9-CM code for DM (250) was not used. 
 
The AC processes were configured as follows:  The maximum number of attributes per rule 
antecedent was 2.  The Apriori minimum support threshold was 0.025; minimum confidence 0.95.  
The specificity threshold was 98, chosen because no viable rules were ranked below 98 in the 
pruning data.  Rules with pruning data set case counts < 3 and PPV < 80 were pruned.  The 
prediction rules generated in the pruning step were evaluated for each of the four sets. 
 
Results 
The sensitivity, specificity and their 95% confidence intervals for each set and the average are 
shown in Table 1.  For a common ICD-9-CM algorithm to identify DM (1 inpatient or 2 outpatient 
codes/2 years), sensitivity (average = 95.8%) was higher than those reported in two large studies:  
72% and 80%.26, 95  Specificity (average = 98.8%) was the same as those reported:  98% and 99%. 
 
SAM- 
PLE FOLD SENS Lo CI Hi CI SPEC Lo CI Hi CI
1 1 95.6 94.1 96.7 98.9 98.1 99.4
1 2 95.8 94.4 96.9 98.7 97.8 99.2
2 1 96.4 95.1 97.4 98.0 96.9 98.7
2 2 95.4 93.9 96.5 99.5 98.8 99.8
AVG 95.8 98.8
 
Table 1 – Sensitivity and Specificity of Rule Sets 
                 with Confidence Intervals (CI) 
                 
The single attributes that participated in any of the four rule sets are shown in Table 2.  These were 
contrasted with single attributes from three published projects that described the identification of 
DM cases from EHR data.96-98  Other than ICD-9-CM codes, all three used elevated laboratory 
glucose assay results that were consistent with national diagnosis guidelines.  One used elevated 
HbA1c results, and one used both HbA1c test orders and elevated results.  One used all 
antihyperglycemic medications, one used all but metformin, and one used only three classes:  
metformin, insulins, and sulfonylureas (insulin release stimulants).  In contrast, the FW did not 
select laboratory glucose assays but identified additional laboratory parameters that discriminated 
DM patients.  Laboratory glucose assays were done in 94% of cases, but an abnormal value 
resulted in only 19% of cases, with exclusiveness of only 87%.  The blood glucose measured by 
professional glucometers during office visits was more predictive.  Tests for blood glucose, urine 
microalbumin and HbA1c were nearly as predictive as their respective abnormal results.   
Metformin, insulins and insulin release stimulants were found to be the strongest rules among 
antihyperglycemics as was noted by Wilke.98  The novel strong rule ‘Diabetic supplies (Pharm 
orders)’ was formed by an aggregate concept over several pharmacy orderables including home 
glucometers, lancets, test strips, diabetic ulcer preparations, and other blood monitoring supplies.  
This rule identified additional DM patients beyond the lab test and medication rules in all sets. 
 
The FW brings a new dimension to disease identification rules with combined attributes (Table 3).  
Metformin is known to generate false positives because it may be used in pre-diabetic conditions.  
However, it is the most common medication for DM.  Table 3 shows metformin combined with 
several other attributes, as it did not form a strong enough rule alone.  The combination with an 
HbA1c test and with a diagnosis or medication for dyslipidemia was consistent across rule sets.  
Both HbA1c tests and abnormal HbA1c results were strong single attributes, but they combined 
with other laboratory tests and attributes to form even stronger rules. 
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The conciseness and generality of the rules is shown in Table 3.  Each set had 10 or 11 rules.  
Eight rules (bold font) were shared in 3 or 4 sets.  Since each set started with ~2,000 rules after 
redundancy pruning, the generality of these machine-generated rules was encouraging.  The rules 
can be further generalized based on the FW’s exposure of patterns in the data, coupled with 
domain knowledge.  For example, separate rule sets can be generated using only HbA1c tests or 
abnormal HbA1c, as these two single attributes cancelled each other out in the pruning and test 
data.  Similarly, urine microalbumin, abnormal urine microalbumin and blood or urine albumin 
covered many of the same cases.  The final step in the FW processes, refinement and iteration, was 
not implemented for this evaluation. 
 
Category                                     




Hmg Coa Reductase Inhibitors 72 79 3
ICD9 272 Disord lipoid metab 82 71 2
Diabetic supplies & services
Diabetic supplies (Pharm orders) 40 100 4
Antihyperglycemics
Insulin Release Stimulant 46 100 4
Insulin Response Enhancer 38 99 2
Insulins 31 100 4
Metformin 64 98 4
Diabetes-related laboratory tests
Glycosylated Hemoglobin (HbA1c) 94 96 4
ABN Glycosyl Hemoglobin (HbA1c) 82 99 4
Microalbumin, Urine 81 97 2
ABN Microalbumin, Urine 62 98 1
Creatinine, Urine 78 96 2
Glucose, Glucometer (Prof) 45 95 3
ABN Glucose, Glucometer (Prof) 42 96 1
Creatinine, Blood or Urine 81 90 4
Albumin, Blood or Urine 81 97 3
Demographic
Age > 47 86 62 1
 




1       
Fold 1
Sample  
1       
Fold 2
Sample  
2       
Fold 1
Sample  
2       
Fold 2
MICROALB_URINE & HbA1c 1 1
ABN_HbA1c & Albumin 10 1 1
Metformin & HbA1c 2 2 2 2
ABN_HbA1c & Creatinine 3 5 6
ABN_MICROALB_URINE & HbA1c 3
Disord_lipoid_metabol & Metformin 11 3
Insulin_Releas_Stimulators 4 4 4 3
Insulin_Resp_Enhancers 9 4
Insulins 5 7 10 6
Hmg_Coa_Reductases & 
ABN_HbA1c 5
Metformin & Hmg_Coa_ 
Reductases 6 9 5
Metformin & Age_GT_47 6
GLUC_GLUCOMETER & 
ABN_HbA1c 7 10 11
DiabSupplies_Pharmacy 8 8 7 7
CREAT_URINE & HbA1c 8
CREAT_URINE & ABN_HbA1c 8
Metformin & Albumin 9
ABN_GLUC_GLUCOMETER & 
ABN_HbA1c 9
Metformin & Creatinine 10
 





The cohort amplification FW offers potential for an efficient generalized approach to derive cohort 
identification rules from EHR data.  The strength of the approach is its ability to discover the 
patterns in the trail of data left by health care providers, who use an incalculable amount of 
professional knowledge to make diagnostic and treatment decisions.  The framework indirectly 
taps into that knowledge.  For diseases and conditions with less organized or shared care 
guidelines, the trail may not be as straightforward as it is for DM.  On the other hand, patterns of 
care for DM are so consistent that one must discard the stronger, dominant attributes to expose 
potential novel associations.  The merit of the rules is based upon many factors including the 
representativeness of the exemplars, the availability of candidate EHR data elements, the coverage 
of relevant evidence for a disease in the EHR (i.e., smoking history), and the strength of class 
association patterns found. 
 
The highly correlated, sparsely populated EHR attributes are well suited to associative 
classification methods.  There are known limitations in the AC methodology.  No causal or 
inductive reasoning is used to form associations.  There are many unexamined correlations among 
the attributes.  Over-fitting rules to exemplars used for training can limit accuracy in the prediction 
task.  Pruning weaker rules to gain a concise, general set of prediction rules helps to minimize this 
problem.  A limitation with the reliability and generalizability of prediction rules is that the 
interestingness metrics, on which rule generation is based, may vary by health care setting, data 
quality, and choice of exemplars. 
 
The FW was designed to be modular and extensible.  There are many potential improvements to 
the processes and algorithms in the FW.  These include linkage to standardized terminologies and 
concept hierarchies, support for sequential patterns, and evaluation of other methods for more 
efficient association, rule discovery and pruning.  Further research on portability across 
organizations would inform our assumption of standardized EHR content.  Further study of the 
reliability and accuracy of the cohort amplification framework applied to asthma is in progress. 
 
Conclusion 
The cohort amplification framework processes and rules generated for identification of DM were 
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RANKING AND PRUNING METHODS DEVELOPED FOR THE  
 





 In this chapter, the process for generating associative classification rules for the 
identification of asthma cases is presented.  The best set of rules was selected on their 
generality and accuracy across ten random training/testing samples.  Novel ranking and 
pruning methods were used to generate the classification rules.  The ranking and pruning 
methods will be described and results compared to a standard method of ranking and 
pruning association rules, known as classification by association.1  Methods for 
evaluating generality and accuracy are described.  The best rules were used in a study of 
the accuracy of identification of asthma cases in a random sample of the EHR, which is 
reported in Chapter 5. 
 
Background 
 Ranking and pruning are critical methods to generate an associative classifier.  In 
association rule mining, a deterministic and deductive task has been performed.  An 
exhaustive set of all associations in the training data, given the constraints, are generated.  
Classification rule discovery is an inductive task, predictive of associations in data not yet 
seen.  Rigorous ranking and pruning strategies are used to select a concise, general and 
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accurate predictive subset of association rules from the exhaustive set.  General and 
concise rules go hand-in-hand because general rules, by definition, cover more cases.  
Therefore, fewer rules are needed.  Both accurate and general rules are preferred in most 
ranking and pruning strategies.  More accurate and more general rules help avoid 
overfitting to the training data.  Rules that are more accurate are more highly associated 
and less likely to be artifacts.  Rules that are more general are more representative of the 
theoretic target population represented by the training data.   
In associative classification, the goal is to take the association rules and form a 
classifier.  To develop the associative classifier, first association rule mining is used to 
discover the rules with the class as the consequent, and then ranking and pruning is 
performed over those rules to form the subset of classifying rules.  Further, their 
predictive accuracy must be evaluated on test data.2  A benefit of associative 
classification is that the ranking and pruning processes and interim results are 
understandable.  The entire process of developing an associative classifier is transparent.  
This enables understanding of the knowledge generated, development of domain specific 
ranking and pruning strategies, and the ability to revise the input data or configuration 
parameters in order to improve the next version of the classifier. 
Associative classifiers were also proven in some studies to be as accurate as the 
classic classification methods.  Chapter 2 contains an extensive literature review on 
associative classification.  Of particular relevance to the pruning strategies described and 






 The study population was described in Chapter 1.  In summary, the population 
sampled for all studies reported in this dissertation was adult patients who had at least 
two health care visits to Intermountain Medical Group family practice or internal 
medicine ambulatory clinics in Salt Lake County at least twice during a four year period, 
2005-2008.  The electronic health records (EHR) of this study population, as stored in the 
Intermountain Health Care Enterprise Data Warehouse, were the source for all data.  The 
EHR covers all health care given by Intermountain employed providers as well as some 
documentation of health care visits to providers affiliated with Intermountain.   
 During development of the cohort amplification framework, the number of 
disease-positive training cases required to generate reliable rules was analyzed.  Training 
set sizes of approximately 1,000 showed too much variability, while sizes of 
approximately 2,000 were as consistent as sizes of 4,000.  In order to generate disease 
exemplar training sets of size ~2,000 with ~1,000 each for pruning and testing of the 
association rules, 3,938 subjects with active asthma coded in the Problem List prior to the 
year 2007 were selected as the disease exemplars.  The asthma codes were developed by 
and for the clinicians using the Problem List.  An approximately equal sized control 
group of 3,948 subjects was randomly selected among the target population having no 
codes for asthma in the Problem List or the hospital or ambulatory encounter records 
during the years 2004-2008. For the intended purpose of classification of asthma cases 
versus no asthma in the EHR data, the control group was defined broadly in order to 
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represent all adult patient records without evidence of asthma.  The training sample sizes 
are balanced so that differences between them are normalized for rules discovery. 
 A description of the core candidate electronic health record data used in the 
cohort amplification framework was presented in Chapter 1.  Direct coded observations, 
aggregate concepts and derived concepts were used from the following EHR data 
sources:  
• Diagnosis and procedure codes (ICD-9-CM codes) 
• Provider and ambulatory clinic procedure codes (CPT codes) 3 
• Provider specialty (local codes) 
• Lab observations (CPT codes) 
• Lab observations with results coded as ‘Abnormal’ 
• Imaging procedures (CPT codes) 
• Medication list (FirstDataBank pharm/chemical groups and ingredients) 4 
• Age > 64 (true) 
• Female gender (true) 
 Single attributes were selected using Apriori association mining methods for 
frequent one-item sets.  This was accomplished in a Java class designed to accept a list of 
observation codes for each exemplar.  The output was a WEKA file containing the 
attributes that met a frequency threshold of 5% among diseases exemplars.  In other 
words, attributes that were populated in less than 5% of the disease exemplars were 
pruned.  A distinction that runs through the entire process of rules generation in the 
cohort amplification framework is a focus solely on rules that predict the disease class 
versus a comparison class.  There were 414 one-item attributes selected for association 
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mining in WEKA and then further ranking, pruning, and testing to form an associative 
classifier.    
 The process of one-item attribute selection using the Apriori algorithm from the 
EHR required manual curation of the attributes.  The EHR query swept all observation 
codes within the categories listed.  Some observation codes were not germane to the 
rules, such as Healthcare Common Procedure Coding System (HCPCS) codes that are 
stored with the CPT codes.  This process was run twice, on both halves of a randomized 
split of the entire data set with a balance of disease and control exemplars.  The 
differences in the frequencies of the 414 one-item attributes were compared by a Paired t 
test.  The differences were not statistically significant (2 tailed p value = .71, 95% 
confidence interval of the difference -0.08 to 0.12).  At sample sizes of ~2,000, the 
frequencies of one-item attributes discovered in the EHR data among asthma exemplars 
were stable.  These two transfers from the EHR to a format suitable for data mining were 
used for the remainder of the rules discovery processes.  Randomly selected examples 
from the 414 one-item attributes are shown in Table 4.1. 
 The 3,938 cases and 3,948 controls were randomly sampled ten times into training 
sets of 1,969 asthma exemplars and 1,974 control exemplars.  The Waikato Environment 
for Knowledge Analysis (WEKA) Knowledge Flow user interface5, 6 was used to 
randomly split the subjects into two sets, stratified on the exemplar status.  One, the 
training set, was used to generate the association rules using the Apriori algorithm7 in 
WEKA version 3.6.2 on a computer with 16 Gb of memory.  The other set was for 
pruning and testing and was stored in a local SQL Server Express database by a 
Knowledge Flow component.  Both sets had an equal number of cases and controls.  The 
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work flow is shown in Figure 4.1.  This process was repeated ten times to generate ten 
random training/pruning/testing samples. 
 The first five samples were analyzed for the maximum number of attributes to 
combine in the antecedents of the association rules.  Since the Apriori algorithm is 
exponential in computing complexity with respect to the number of combinations 
performed, the lowest maximum number of attributes which achieves accurate rules is 
best.8  Redundant rules are not formed, and lower minimum support thresholds can be 
reached by the Apriori algorithm.  The five samples were consistently more accurate, by 
sensitivity and specificity on test data, when combinations were constrained at three 
attributes versus two.  This computing complexity is estimated as (414)3.  On the other 
hand, the best rules by rank, sensitivity gain, specificity loss, and agreement across 
samples had one or two attribute rule antecedents.  In addition, rules having one or two 
attribute antecedents are more general rules, and therefore, preferred.  Four-attribute 
combinations are of estimated computing complexity (414)4, which is difficult to 
accommodate in computer memory for WEKA Apriori association mining.  To 
accomplish it, the frequency threshold for the algorithm must be set higher.  The trade-off 
in frequency to gain four- attribute antecedents with low rank and low generality was not 
attempted.  The lowest frequency among disease exemplars that was reached with the 
three attribute maximum was 8%.  A comparison with rules generated at a two attribute 
maximum, which reached 5% frequency among disease exemplars, showed that no rules 
were missed by losing attributes with only 5-7% frequency among disease exemplars. 
 Five more samples with three attribute association rules were generated.  The ten 
sets of random samples of the exemplar data, each with candidate rules generated with a 
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maximum of three attribute rule antecedents in WEKA, were then used to create 
associative classification rules using ranking and pruning methods developed for the 
cohort amplification framework.  The methods are shown to perform better than classic 
ranking and pruning methods for this application.  One best set of rules to identify asthma 
cases in the EHR was selected from the rules generated in the ten random samples.  
 
Ranking and Pruning 
 The Apriori algorithm implemented in WEKA was used to perform the 
association rule mining step, constrained to a maximum of three attributes per rule 
antecedent and constrained to the exemplar status or ‘class’ as the rule consequent.  The 
minimum frequency or support was set at 8% for the disease class (4% overall).  WEKA 
provided an output file with all frequent-item sets with their total count and their class 
count.   In the framework, three downstream associative classification pruning steps were 
implemented using the output.  Ranking and pruning were performed on separate training 
data from the set used to create the rules. 
 
Redundant Rule Pruning  
 Classification based on multiple association rules (CMAR)9, a classic associative 
classification model, introduced the redundancy pruning method.  Redundancy pruning is 
implemented before the rules are ranked.  Multiattribute rules that cover the same or 
fewer cases and do not improve the confidence of a more general rule, e.g., a subset of 
the multi-attribute rule, are redundant.  If rule ‘Ra’ was met, then rule ‘Ra U Rb’ is 
redundant unless its confidence is greater.  Rule ‘Ra U Rb’ (child rule) cannot have more 
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support than ‘Ra’ (parent rule).  At most, it can have equal support.  The redundancy 
pruning method results in fewer, more general rules. 
 In the framework, a Java class parsed the WEKA output file and created a 
directed acyclic graph of the single attribute relations to their combinations and 
calculated and stored the local support and exclusiveness metrics for each.  Local support 
is the frequency of occurrence in the disease class, and exclusiveness is the normalized 
likelihood of the disease class occurring as the rule’s consequent.10  The exclusiveness 
metric is equal to the confidence metric for equal training sample sizes.  Although the 
exclusiveness metric is not representative of the population to which the rules will be 
applied, its relative values are consistent with the confidence metric and valid for ranking 
purposes.  The Java class pruned redundant rules and generated an output file with the 
remaining rules and their metrics for the next pruning steps. 
 
Database Coverage Pruning 
 The initial associative classification model, known as ‘classification by 
association’ (CBA), introduced the database coverage method.1  More than one rule may 
cover the same case to be classified.  The rules discovered by association rule mining are 
ranked in order of confidence, then support.  Processing the rules in ranked order, the 
training cases that meet the rule are removed from further consideration by a subsequent 
rule.  If no case meets a rule, the rule is pruned.  This continues until all training cases 
have been covered or all rules were tested.  Cases left uncovered are assigned to the class 
with the highest frequency in the training data.   The database coverage method seeks the 
most accurate rules, by rank, and eliminates less accurate rules that cover the same cases.
 Database coverage was implemented in the framework on the set of rules pruned 
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for redundancy.  In the EHR data used in the framework, as is true in transaction data in 
general, there are naturally co-occurring attributes in the data because they describe the 
same processes.  This was one of the main assumptions of the original association rule 
mining approach, but it leaves a conundrum for associative classification rules.  Small 
differences in rank can generate different sets of rules over samples of the same training 
data.  This is because selected rules in rank order will cover others that follow, which will 
be pruned if all their cases were previously covered.  The varying rules might predict the 
class equally well on the test data, but inconsistent rule sets are not appreciated by users.  
Otherwise, the associative classification rules are quite amenable to domain expert 
understanding.  Since one of the goals of the framework is to generate understandable as 
well as concise, general and accurate classifiers, a new ranking algorithm was developed 
to overcome this inconsistency. 
 
Framework Ranking and Pruning Improvements 
 The ranking was based on the principle of generality and also requires 
specification of a lower bound on the acceptable specificity for the set of rules.  
Sensitivity and specificity are trade-offs for accuracy of the rules.  The threshold could be 
placed on either.  However, it made more sense to specify the tolerance for incorrect 
classification, depending upon the intended application of the rules.  An abbreviated 
example is shown in Table 4.2.  With the rules ranked according to CBA, the specificity 
is calculated on a pruning data set.  The rules at or above the specificity threshold are 
reranked according to their absolute frequency (descending) among disease exemplars in 
the pruning data set.  Within absolute frequency, rules are ranked by exclusiveness 
(descending), then cardinality (ascending).  The CBA database coverage pruning 
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algorithm is executed on this reranked subset of rules, with further constraints to avoid 
over-fitting.  Rules that covered less than five disease exemplars were pruned, rather than 
the CBA algorithm’s acceptance of a rule that classified even one case.  Rules with a 
positive predictive value (PPV) less than 70 on the pruning data set were pruned. 
 The reranking by absolute frequency among disease exemplars promotes 
generality of the rules.  The higher ranking of more frequent attributes also results in 
attributes of more general concept levels covering all cases of any child concept levels.  
The duplicative and less general attribute will be pruned from the rules.  Since the rules 
most likely to cover disease exemplars are executed first, it was hypothesized that fewer, 
more frequent rules would be generated.  Pruning lower ranked rules was hypothesized to 
reduce misclassifications, resulting in better accuracy.  The requirement for a rule to 
cover at least five disease exemplars also supports generality.  The PPV constraint 
supports accuracy.  Generality will be measured by conciseness of the rule sets based on 
the number of rules.  Accuracy will be measured by the specificity of the rule sets.  
 Rules that survive pruning become the rule sets for each of the ten training sets.  
The sensitivity and specificity of the rules sets were assessed on test data set aside for 
each of the ten training sets.  The pruning methods developed for the framework were 
compared to the CBA methods on conciseness and sensitivity.  Conciseness is defined as 
the total count of rules in the set.  The framework pruning method was based on a 
threshold set on the specificity derived by CBA pruning methods and was the point at 
which the two processes deviated.  The specificities after the framework pruning process 
were usually improved above the thresholds, even though the subsequent specificity was 
measured on separate test data.  Specificity and sensitivity are bound, moving in opposite 
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directions.  For comparison of accuracy, the framework rule set sensitivity will be 
compared to the CBA sensitivity at the same specificity.   
 
 
Selection of the Best Rules 
 The best rules were selected from the ten training sets to identify asthma cases in 
the EHR based on their consensus across samples (generality) and their accuracy.  It was 
preferable to take a general set of rules from all ten training sets than to take the rules 
from one set, which performed well on the test data.   The ratio of the average sensitivity 
gain to the average specificity loss of the rule was calculated on test data.  The order of 
each rule in its rule set influences the actual contribution to sensitivity and specificity.  
Higher ordered rules cover more cases and leave fewer for subsequent rules to classify.  
There may be further bias in the uncovered cases.  The stronger associations execute first 
and the weaker lower ordered rules get the left-over cases.  The ratio of average 
sensitivity gain to average specificity loss is independent of the order and is an index of 
correct prediction to misclassification for each rule on the test data. 
 
Results 
 The five most accurate training sets on test data are shown in Table 4.3.  These 
had both the best sensitivity and the best specificity.  The remaining five sets are shown 
in Table 4.4.  For each ordered rule in each training set, the accruing sensitivity and 
specificity loss (the false positive accrual as a percentage of the true negatives) are shown 
as well as the contribution by each rule. 
 Table 4.5 shows the generality and accuracy measures for the ten training sets.  
The number of rules and sensitivity are shown for the rule sets pruned by framework 
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methods and pruned by CBA.  The specificity attained by the framework methods is 
shown.  The sensitivities for both methods are reported at this specificity.  Conciseness of 
the rules was dramatically improved with the framework pruning methods.  At a constant 
specificity, the sensitivity in the framework pruning methods was higher in seven training 
sets, equal in one, and slightly lower than the CBA pruning method sensitivity.  The 
average sensitivity using framework pruning was 58.2%.  The average for CBA pruning 
was 56.4%.  The difference in the sensitivity over the ten training sets was statistically 
significant (p = .028, 95% confidence interval 0.24-3.3) by a paired t test.  The 
framework pruning methods resulted in a modest improvement in accuracy. 
 The ten sets generated a fairly consistent sets of rules (Table 4.6).  The rules 
shown in italicized font were covered by a more general rule in the collection.  Usually 
these were three-attribute rules that were covered by a two-attribute rule.  However, 
‘Asthma Procedures’ (CPT 94010, BREATHING CAPACITY TEST; CPT 94640, 
AIRWAY INHALATION TREATMENT) was a conceptual subset of ‘Other Pulmonary 
Procedures’ (CPT 94010; CPT 94640, CPT 94240, RESIDUAL LUNG CAPACITY; 
CPT 94060, EVALUATION OF WHEEZING,BRONCHODIL RESPN PRE&POST 
DILAT; CPT 94720, MONOXIDE DIFFUSING CAPACITY).  No general-specific pair 
was generated in the same rule set since the ordering by absolute frequency forced the 
more general concept first.  The more general rule of a pair was preferred for the best set. 
 Rules were selected for the best set if the average sensitivity gain to average 
specificity loss ratio was 4 or greater because the most consistent rules, those that 
occurred in at least four rule sets, had a ratio greater than 4.  This ratio corresponds to an 
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80% likelihood that the rule, given its order, improved the overall accuracy of 
classification on test data. 
 The best rules are shown in Table 4.7.  They will be used in Chapter 5 to 
classify asthma cases in a random sample from the study population. 
 
Discussion and Conclusions 
 The processes used to generate a set of associative classification rules to identify 
asthma cases in the electronic health record were described.   An overview of the cohort 
amplification framework processes and workflow was described in Chapter 3.  In this 
chapter, the focus was the ranking and pruning processes developed for the framework in 
order to gain more general rules than were generated using the classic CBA methods.  
Compared to CBA, the framework ranking and pruning strategies improved both 
generality and accuracy of the rules on test data.     
 Improvements in rule ranking was listed as one of the interesting research 
directions in associative classification.11  Rule preference affects the accuracy of the 
classifier.  Two novel ranking approaches were introduced in this study.  The calculation 
of the sensitivity and specificity of the CBA-ranked rules on training data presented a 
metric that is familiar in the application domain.  Secondly, rules at or above a lower 
bound on the acceptable specificity, a parameter setting for the application at hand, were 
re-ranked according to the absolute frequency at which the rule was satisfied in the 
pruning data set.  This forced the most general rules to execute first.  This not only solved 
the problem of generating rules that are more consistent across training samples, it also 
automated the selection of the most general concept if multiple concept hierarchies were 
  
72
present.  The rules ‘Asthma Procedures’ and ‘Other Pulmonary Procedures’, discussed in 
the Results section, are examples of the latter.  
 More conservative pruning strategies than those in CBA were used.  Pruning may 
have a domain-specific rationale.  The two objectives are to remove redundant and 
misleading rules for the classification task at hand.  Redundant rule pruning was used as 
described in the classic CMAR method.   Since the candidate EHR data represented 
routine processes of health care, the data were inherently highly associated.  To avoid 
over-fitting in this domain, higher thresholds were set on the number of training cases 
covered (generality) and the positive predictive value (accuracy) of each rule.  As a 
further step to avoid over-fitting, a separate slice of the training data was used to perform 





Table 4.1  Random Examples of 414 EHR Candidate Attributes 
                 Frequencies Among Asthma Exemplars 
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ALLERGY_SRVC AND Glucocorticoid 
AND Other_Pulmonary_Procedure 1 3 3 99.7 71
Salmeterol AND Diagnostic_Radiology 2 3 6 99.4 81
Glucocorticoid AND Albuterol AND 
Allergic_rhinitis 3 2 8 99.2 70
Leukotriene_Receptor AD Albuterol 4 0 8 99.2 85
Albuterol AND Montelukast 5 0 8 99.2 83
Salmeterol AND 
Need_for_prophylactic_vac 6 4 12 98.8 132
Salmeterol AND FLU_VACCINE 7 1 13 98.7 137
Albuterol AND Salmeterol 8 0 13 98.7 126
Antihistamines AND Salmeterol 9 1 14 98.6 123
Salmeterol AND 
IMMUNZATN_ADMIN 10 0 14 98.6 122
Salmeterol AND Hmg_Coa_Reducta 12 0 14 98.6 94
Salmeterol AND Oth_and_unspecified 13 0 14 98.6 109
Albuterol AND Fluticasone AND 
isFemale 14 0 14 98.6 118
Albuterol AND ABN_LIPID_PANEL 
AND isFemale 15 2 16 98.4 106
Leukotriene AND age_GT_47 AND 




Table 4.3  Five Most Accurate Rule Sets of the Ten Training Sets 
 
Set R ule
R ule  
Orde r
Sen si - 
tiv ity  
Ac c ru al
S e ns . 
Ga in 
Th is  
R ule
S p ec i- 
fici ty 
A cc rua l
Sp ec . 
L os s 
T his  
R ul e
1 c30 00252 433_S a lm ete ro l 1 3 2.5 3 2.5 9 9 .0 1 .0
c30 0 02 50 3 86 _ G luco co rticoid AND  
c30 0 02 52 4 25 _ A lb utero l 2 4 4.2 1 1.7 9 8 .3 0 .7
c30 0 02 50 6 52 _ Le u kot rie n e_ Re c_ A ntag 3 5 0.8 6.6 9 8 .0 0 .3
c30 0 02 50 3 86 _ G luco co rticoid AND  
Asth m aPro ce du re s_cp t9 4 01 0 4 5 4.2 3.4 9 7 .9 0 .1
c30 0 02 52 4 25 _ A lb utero l AN D 
c82 9 47 _G LU C _B L D _L AB __ Q U AN T 5 5 7.0 2.8 9 7 .3 0 .6
BetaAd ren e rgH ic3N o tA lb u tO_ L 32 6 5 8.7 1.7 9 7 .3 0 .0
2 c30 00252 433_S a lm ete ro l 1 3 1.9 3 1.9 9 9 .3 0 .7
c30 0 02 50 3 86 _ G luco co rticoid AND  
c30 0 02 52 4 25 _ A lb utero l 2 4 4.1 1 2.2 9 8 .7 0 .6
c30 0 02 50 3 86 _ G luco co rticoid AND  
Asth m aPro ce du re s_cp t9 4 01 0 3 4 8.3 4.2 9 8 .3 0 .4
c30 0 02 50 6 52 _ Le u kot rie n e_ Re c_ A ntag 4 5 3.6 5.3 9 7 .9 0 .4
BetaAd ren e rgH ic3N o tA lb u tO_ L 32 5 5 5.7 2.1 9 7 .9 0 .0
c30 0 02 52 4 25 _ A lb utero l AN D 
c78 0 _G en er al_sym p to m s 6 5 7.7 2.0 9 7 .2 0 .7
c30 0 02 50 3 86 _ G luco co rticoid AND  
Oth e r_Pu lm on a ry_ P roce d ure  AN D  is Fem ale 7 5 8.0 0.3 9 6 .9 0 .3
3 c30 00252 433_S a lm ete ro l 1 3 3.9 3 3.9 9 9 .3 0 .7
c30 0 02 50 3 86 _ G luco co rticoid AND  
c30 0 02 52 4 25 _ A lb utero l 2 4 5.0 1 1.1 9 8 .5 0 .8
c30 0 02 50 6 52 _ Le u kot rie n e_ Re c_ A ntag 3 5 2.0 7.0 9 7 .9 0 .6
c30 0 02 50 3 86 _ G luco co rticoid AND  
Asth m aPro ce du re s_cp t9 4 01 0 4 5 4.8 2.8 9 7 .4 0 .5
c30 0 02 52 4 25 _ A lb utero l AN D isFe m a le 5 5 7.2 2.4 9 7 .0 0 .4
BetaAd ren e rgH ic3N o tA lb u tO_ L 32 6 5 8.9 1.7 9 6 .9 0 .1
c82 9 47 _G LU C _B L D _L AB __ Q U AN T A N D  
Asth m aPro ce du re s_cp t9 4 01 0 A ND  
ast hm aC om orb ids_ 47 3 7 5 9.1 0.2 9 6 .8 0 .1
c30 0 02 52 4 25 _ A lb utero l AN D 
Urin alysis_ _b y_d ip _ stick 8 5 9.8 0.7 9 6 .8 0 .0
4 c30 00252 433_S a lm ete ro l 1 3 3.3 3 3.3 9 8 .7 1 .3
c30 0 02 50 3 86 _ G luco co rticoid AND  
c30 0 02 52 4 25 _ A lb utero l 2 4 4.5 1 1.2 9 8 .0 0 .7
c30 0 02 50 6 52 _ Le u kot rie n e_ Re c_ A ntag 3 4 9.9 5.4 9 7 .6 0 .4
c30 0 02 50 3 86 _ G luco co rticoid AND  
Asth m aPro ce du re s_cp t9 4 01 0 4 5 3.1 3.2 9 7 .1 0 .5
c30 0 02 52 4 25 _ A lb utero l AN D isFe m a le 5 5 5.2 2.1 9 6 .4 0 .7
BetaAd ren e rgH ic3N o tA lb u tO_ L 32 6 5 7.1 1.9 9 6 .4 0 .0
c30 0 02 52 4 25 _ A lb utero l AN D 
c85 0 25 A __ AB N _C OM P L ETE_ CB C 7 5 7.4 0.3 9 6 .4 0 .0
c84 4 43 _AS SA Y_ TH YRO ID _S T IM  AN D 
Asth m aPro ce du re s_cp t9 4 01 0 8 5 8.7 1.3 9 5 .8 0 .6
5 c30 00252 433_S a lm ete ro l 1 3 1.0 3 1.0 9 8 .9 1 .1
c30 0 02 50 3 86 _ G luco co rticoid AND  
c30 0 02 52 4 25 _ A lb utero l 2 4 3.7 1 2.7 9 8 .1 0 .8
c30 0 02 50 6 52 _ Le u kot rie n e_ Re c_ A ntag 3 4 9.0 5.3 9 7 .5 0 .6
c30 0 02 50 3 86 _ G luco co rticoid AND  
Oth e r_Pu lm on a ry_ P roce d ure 4 5 3.4 4.4 9 6 .9 0 .6
c30 0 02 52 4 25 _ A lb utero l AN D 
Urin alysis_ _b y_d ip _ stick 5 5 5.4 2.0 9 6 .4 0 .5
BetaAd ren e rgH ic3N o tA lb u tO_ L 32 6 5 7.6 2.2 9 6 .3 0 .1
Asth m aPro ce du re s_cp t9 4 01 0 A ND  




Table 4.4  Five Least Accurate Rule Sets of the Ten Training Sets 
 
S et R ule
R ule  
Orde r
S en si - 
tiv ity  
Ac c ru al
S e ns . 
Ga in 
Th is  
R ule
S p ec i- 
fici ty 
A cc rua l
S p ec . 
L os s 
T his  
R ul e
6 c30 00252 433_S a lm ete ro l 1 3 1.0 3 1.0 9 9 .1 0 .9
c30 0 02 50 3 86 _ G luco co rticoid A ND  
c30 0 02 52 4 25 _ A lb utero l 2 4 2.7 1 1.7 9 8 .2 0 .9
c30 0 02 50 6 52 _ Le u kot rie n e_ Re c_ A ntag 3 4 9.1 6.4 9 8 .0 0 .2
c30 0 02 50 3 86 _ G luco co rticoid A ND  
O th e r_P u lm on a ry_ P roce d ure 4 5 2.5 3.4 9 7 .3 0 .7
c30 0 02 52 4 25 _ A lb utero l A N D isFe m a le 5 5 4.9 2.4 9 6 .7 0 .6
B etaA d ren e rgH ic3N o tA lb u tO_ L 32 6 5 7.1 2.2 9 6 .7 0 .0
c30 0 02 52 4 25 _ A lb utero l A N D 
c82 9 47 _G LU C _B L D _L A B __ Q U A N T A N D  
GT _5 _F F_ V is_ P er _Y r 7 5 7.5 0.4 9 6 .5 0 .2
7 c30 00252 433_S a lm ete ro l 1 3 2.1 3 2.1 9 9 .0 1 .0
c30 0 02 50 3 86 _ G luco co rticoid A ND  
c30 0 02 52 4 25 _ A lb utero l 2 4 3.5 1 1.4 9 8 .5 0 .5
c30 0 02 50 6 52 _ Le u kot rie n e_ Re c_ A ntag 3 4 9.5 6.0 9 7 .9 0 .6
c30 0 02 50 3 86 _ G luco co rticoid A ND  
c82 9 47 _G LU C _B L D _L A B __ Q U A N T A N D  
O th e r_P u lm on a ry_ P roce d ure 4 5 2.6 3.1 9 7 .3 0 .6
c30 0 02 52 4 25 _ A lb utero l A N D 
c82 9 47 _G LU C _B L D _L A B __ Q U A N T A N D  5 5 3.9 1.3 9 7 .1 0 .2
B etaA d ren e rgH ic3N o tA lb u tO_ L 32 6 5 6.0 2.1 9 7 .0 0 .1
c30 0 02 53 0 44 _ Flut ica son e  A N D 
c78 2 _S ym p to m s_in volv in g _sk in  A N D 
GT _5 _F F_ V is_ P er _Y r 7 5 6.5 0.5 9 6 .5 0 .5
c2_ A L LE R GY  S E R V IC E  A ND  
O th e r_P u lm on a ry_ P roce d ure 8 5 7.1 0.6 9 6 .4 0 .1
8 c30 00252 433_S a lm ete ro l 1 3 1.4 3 1.4 9 9 .2 0 .8
c30 0 02 50 3 86 _ G luco co rticoid A ND  
c30 0 02 52 4 25 _ A lb utero l 2 4 3.5 1 2.1 9 7 .9 1 .3
c30 0 02 50 3 86 _ G luco co rticoid A ND  
O th e r_P u lm on a ry_ P roce d ure 3 4 8.0 4.5 9 7 .0 0 .9
c30 0 02 50 6 52 _ Le u kot rie n e_ Re c_ A ntag 4 5 4.1 6.1 9 6 .4 0 .6
c30 0 02 52 4 25 _ A lb utero l A N D isFe m a le 5 5 6.7 2.6 9 5 .7 0 .7
c30 0 02 52 4 25 _ A lb utero l A N D 
GT _5 _F F_ V is_ P er _Y r 6 5 7.9 1.2 9 5 .4 0 .3
B etaA d ren e rgH ic3N o tA lb u tO_ L 32 7 5 8.3 0.4 9 5 .4 0 .0
9 c30 00252 433_S a lm ete ro l 1 3 0.8 3 0.8 9 9 .0 1 .0
c30 0 02 50 3 86 _ G luco co rticoid A ND  
c30 0 02 52 4 25 _ A lb utero l 2 4 2.2 1 1.4 9 7 .9 1 .1
c30 0 02 50 6 52 _ Le u kot rie n e_ Re c_ A ntag 3 4 9.6 7.4 9 7 .2 0 .7
c30 0 02 52 4 25 _ A lb utero l A N D 
c82 9 47 _G LU C _B L D _L A B __ Q U A N T 4 5 1.4 1.8 9 6 .5 0 .7
c30 0 02 50 3 86 _ G luco co rticoid A ND  
c82 9 47 _G LU C _B L D _L A B __ Q U A N T 
O th e r_P u lm on a ry_ P roce d ure _ L2 6 5 5 5.8 4.4 9 5 .5 1 .0
B etaA d ren e rgH ic3N o tA lb u tO_ L 32 6 5 8.3 2.5 9 5 .4 0 .1
1 0 c30 00252 433_S a lm ete ro l 1 3 1.1 3 1.1 9 8 .5 1 .5
c30 0 02 50 3 86 _ G luco co rticoid A ND  
c30 0 02 52 4 25 _ A lb utero l 2 4 2.8 1 1.7 9 7 .6 0 .9
c30 0 02 50 6 52 _ Le u kot rie n e_ Re c_ A ntag 3 4 9.7 6.9 9 6 .7 0 .9
c30 0 02 50 3 86 _ G luco co rticoid A ND  
O th e r_P u lm on a ry_ P roce d ure 4 5 3.3 3.6 9 5 .9 0 .8
S eru m E lect roly tes  A ND  
A sth m aP ro ce du re s_cp t9 4 01 0 5 5 4.3 1.0 9 4 .6 1 .3
c30 0 02 52 4 25 _ A lb utero l A N D 
c85 0 25 A __ A B N _C OM P L E TE _ CB C 6 5 5.8 1.5 9 4 .4 0 .2




Table 4.5  Generality and Accuracy of Rules 













1 6 97.3 58.7 33 53.2
2 7 96.9 58.0 52 57.1
3 8 96.8 59.8 52 58.6
4 8 95.8 58.7 48 55.5
5 7 95.8 58.1 57 57.5
6 7 96.7 57.1 61 54.7
7 8 96.4 57.1 54 57.9
8 7 95.4 58.3 70 58.3
9 6 95.4 58.3 45 53.5
10 7 94.4 57.6 61 57.7
Average Sensitivity:  58.2 56.4
Paired t Test of Sensitivity Differences in Sets
     95% Confidence Interval:
     2-tailed p value:
0.24 - 3.3
0.03


























Table 4.6  All Rules Over Ten Training/Validation Sets 
 
R u l e
N u m . 
o f 
R u le  
S e ts
L o c a l 
S u p - 
p o r t
A v g  
S e n s i -  
t i v i ty
A v g  
S p e c i-  
f i c i ty
R a tio  
S e n s .  
to  
S p e c .
c 3 0 0 0 2 5 2 4 3 3 _ S a l m e t e r o l _ _ H i 1 0 3 2 3 1 .9 1 .0 3 1 . 9
c 3 0 0 0 2 5 0 3 8 6 _ G l u c o c o r ti c o i d  
c 3 0 0 0 2 5 2 4 2 5 _ A lb u t e r o l _ _ H i c 3 1 0 2 5 1 1 .7 0 .8 1 4 . 1
c 3 0 0 0 2 5 0 6 5 2 _ L e u k o t r i e n e _ R e c _ A n ta g 1 0 2 0 6 .2 0 .5 1 1 . 8
B e ta A d r e n e r g H i c 3 N o tA l b u t O r S a l m e r o l 1 0 9 1 .9 0 .0 4 6 . 5
c 3 0 0 0 2 5 0 3 8 6 _ G l u c o c o r ti c o i d  A N D  
O t h e r _ P u l m o n a r y _ P r o c e d u r e _ L 2 6 4 2 1 4 .0 0 .8 5 . 3
c 3 0 0 0 2 5 0 3 8 6 _ G lu c o c o r t i c o i d  A N D  
A s th m a P ro c e d u re s_ c p t 9 4 0 1 0 4 1 8 3 .4 0 .4 9 . 1
c 3 0 0 0 2 5 2 4 2 5 _ A lb u t e r o l _ _ H i c 3  A N D  
i sF e m a l e 4 2 0 2 .4 0 .6 4 . 0
c 3 0 0 0 2 5 2 4 2 5 _ A lb u t e r o l _ _ H i c 3  A N D  
c 8 5 0 2 5 A _ _ A B N _ C O M P L E T E _ C B C 2 1 7 0 .9 0 .1 9 . 0
c 3 0 0 0 2 5 2 4 2 5 _ A lb u t e r o l _ _ H i c 3  A N D  
U r i n a l y s is _ _ b y _ d ip _ s ti c k 2 1 6 1 .4 0 .3 5 . 4
c 3 0 0 0 2 5 0 3 8 6 _ G lu c o c o r t i c o i d  A N D  
c 8 2 9 4 7 _ G L U C _ B L D _ L A B _ _ Q U A N T  A N D  
O t h e r _ P u l m o n a ry _ P ro c e d u re 2 1 8 3 .8 0 .8 4 . 7
c 3 0 0 0 2 5 2 4 2 5 _ A lb u t e r o l_ _ H ic 3  A N D  
c 8 2 9 4 7 _ G L U C _ B L D _ L A B _ _ Q U A N T 2 2 2 2 .3 0 .7 3 . 5
c 2 _ A L L E R G Y _ S E R V IC E  A N D  
O t h e r _ P u l m o n a r y _ P r o c e d u r e _ L 2 6 1 9 0 .6 0 .1 6 . 0
c 3 0 0 0 2 5 2 4 2 5 _ A lb u t e r o l_ _ H ic  A N D  
c 8 2 9 4 7 _ G L U C _ B L D _ L A B _ _ Q U A N T  A N D  
G T _ 5 _ F F _ V is _ P e r _ Y r_ N O _ D E S 1 1 7 0 .4 0 .2 2 . 0
c 3 0 0 0 2 5 2 4 2 5 _ A lb u te r o l _ _ H ic 3  A N D  
c 8 2 9 4 7 _ G L U C _ B L D _ L A B _ _ Q U A N T  A N D  
i sF e m a le 1 1 7 1 .3 0 .2 6 . 5
c 3 0 0 0 2 5 2 4 2 5 _ A lb u t e r o l_ _ H ic 3  A N D  
G T _ 5 _ F F _ V is _ P e r _ Y r 1 1 9 1 .2 0 .3 4 . 0
c 3 0 0 0 2 5 2 4 2 5 _ A lb u t e r o l_ _ H ic 3  A N D  
c 7 8 0 _ G e n e ra l _ s ym p t o m s 1 1 4 2 .0 0 .7 2 . 9
c 8 2 9 4 7 _ G L U C _ B L D _ L A B _ _ Q U A N T  A N D  
A s th m a P ro c e d u re s_ c p t9 4 0 1 0  A N D  
a s t h m a C o m o rb id s _ 4 7 3 1 9 0 .2 0 .1 2 . 0
c 3 0 0 0 2 5 0 3 8 6 _ G lu c o c o r t i c o i d  A N D  
O t h e r _ P u l m o n a ry _ P ro c e d u re _ L 2 6  A N D  
i sF e m a le 1 1 5 0 .3 0 .3 1 . 0
S e ru m E l e c t ro l y te s  A N D  
A s th m a P ro c e d u re s_ c p t9 4 0 1 0 1 1 8 1 .0 1 .3 0 . 8
c 8 4 4 4 3 _ A S S A Y _ T H Y R O ID _ S T IM _  A N D  
A s th m a P ro c e d u re s_ c p t9 4 0 1 0 1 1 3 1 .3 0 .6 2 . 2
A s th m a P ro c e d u re s_ c p t9 4 0 1 0  A N D  
V 0 4 _ N e e d _ f o r_ p ro p h yl a c t i c _ v a c c in e 1 1 1 0 .5 0 .5 1 . 0
c 3 0 0 0 2 5 3 0 4 4 _ F lu ti c a so n e  A N D  
c 7 8 2 _ S ym p t o m s_ i n v o lv i n g _ s k in  A N D  





Table 4.7  Best Rules Selected Among Ten Training Sets 
 
Rule 
Number Rule Data Source
1 Salmeterol Med ingredient
2 Glucocorticoid AND Albuterol Med class
3 Leukotriene Receptor Antagonist Med class
4




Other_Pulmonary_Procedure Med class, CPT aggregate*
6 Albuterol AND Female Med ingredient, Demographic feature
7
Allergy_S pecialis t_Visit AND 
Other_Pulmonary_Procedure Visit feature, CP T aggregate
8 Albuterol AND Abnormal_CBC Med ingredient, Lab abnormalit y
9
Albuterol AND 
Urinalys is_by_dip_stick Med ingredient, Lab order
* Breathing capacity tes t, airwa y inhalat ion treatment, pulse oxim etry, monoxide 
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ACCURACY OF COHORT AMPLIFICATION FRAMEWORK 
 




 The proposed value of the general disease cohort amplification framework was to 
learn the rules from known cases and apply them to identify additional cases.  A 
validation study of the rules generated for asthma was performed to test the accuracy of 
the rules to identify new cases in the EHR.  Validation is a recommended step in the 
application of framework rules in an EHR setting because it is a standard practice when 
introducing any new algorithm to identify cases for research.  The specific objectives of 
such validation studies may vary.  There may be use-case specific requirements for proof 
of accuracy.  Various reference standards may be available or preferred.  The current 
study was not intended for generality of the design.  The purpose was to demonstrate the 
value of a set of predictive rules generated by the cohort amplification framework to 
identify additional asthma cases in the same EHR setting. 
 The accuracy of the rules was tested on a random sample of 992 subjects in the 
original study population, described in Chapter 1.  These subjects were not used to 
generate the rules.   The validation set subjects were classified as positive or negative 
according to a composite reference standard developed for this study.  The rules were 
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executed against the validation set.  Accuracy was assessed by sensitivity and specificity 
of the rules.  A practical value of the rules was explored by evaluation of the sensitivity 
gain when rules were combined with a validated ICD-9-CM based algorithm to identify 
cases. 
 There was no existing gold standard for identification of asthma patients in the 
study population or the resources to generate one.  A composite reference standard (CRS) 
was developed from a combination of two imperfect but accepted standards and clinician 
review of provider documentation of care.  The CRS consisted of various versions of 
asthma documentation in the EHR.  By design, the framework used standard EHR 
content generated by routine health care delivery processes and documentation.  Rules to 
identify additional cases used the same EHR content.  Therefore, the reference standard 
positives for the validation study were patients who were considered to have asthma 
according to the medical records.  The three components of the composite reference 
standard were asthma Problem List codes, asthma ICD-9-CM codes, or statements 
interpreted as a probable diagnosis of asthma in the clinical text documentation in the 
Intermountain Healthcare EHR.   
 Because the prevalence of asthma was estimated to be 11 % in the study 
population, approximately 89 % of the test set was expected to be negative.  Many of the 
positive cases were determined by the coded evidence.  There were not resources to 
review the clinical text documents of all those with no coded evidence of asthma to find 
the additional asthma cases.  Text mining was used to select the most likely positive cases 
among those with no coded evidence.  The likely cases were reviewed by clinicians.  The 
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text mining method was validated, and the expected error in the composite reference 






 The evaluation of the accuracy of a diagnostic test or predictive algorithm in 
clinical and epidemiologic research requires a standard for comparison.  The perfect 
standard is commonly called a ‘gold’ standard and is always preferred for research 
purposes.  However, there are often circumstances that prevent the use of a gold standard.  
The gold standard level of proof may be autopsy or an invasive test that cannot ethically 
be performed on all subjects.  The restrictions may be costs and resources associated with 
a thorough clinical review of cases or issues with access to the definitive records.  In 
research situations where a less than perfect standard of comparison must be used, the 
standard is called a ‘reference’ standard.  Methods that accommodate imperfect reference 
standards have been reported in the statistical and epidemiologic literature.  Two recent 
review articles offered guidelines for appropriate methods.1, 2  A composite reference 
standard was used to evaluate the accuracy of framework-generated rules to identify new 
asthma cases in the EHR because it enabled the use of multiple sources of evidence found 
in the electronic medical records.  Statistical adjustment of one component of the 
composite reference standard was used to accommodate known error in the text mining 





Composite Reference Standards 
 The composite reference standard was described for situations when multiple 
imperfect reference standards may be combined to form a better, although still imperfect, 
reference standard.  The composite reference standard is an empirical methodology to 
leverage the available evidence.    The level of proof stands on the acceptability of the 
combined evidence to consumers of the research. 
 Alonzo and Pepe3, 4 described the composite reference standard (CRS) for binary 
outcomes: positive or negative. It is a staged approach in which one reference standard is 
applied.  Cases not covered are then subjected to another reference standard.  The 
examples of the use of this methodology were situations in which the first reference 
standard had good specificity, e.g., provided a believable level of proof that a positive 
determination was truly positive.  However, the first reference standard had unacceptable 
sensitivity.  Examples were diagnostic tests that would have been routinely applied if 
there were a clinical suspicion for the positive outcome and were not practical or ethical 
to apply when there was no evidence.  Those that are covered by the first reference 
standard are considered resolved.  The subsequent reference standard may be considered 
the ‘resolver’.  The generic model is diagrammed in Table 5.1.      
 Other than enabling the evaluation of a new test where no gold standard exists, 
the CRS provides a straightforward, deterministic reference standard based on observable 
evidence.  Several sources of evidence can be used, which is a practical approach to the 
sparse nature of many observations in the electronic health record.  In addition to the 
common clinical workflow of performing diagnostic tests differentially based on prior 
evidence, the evidence may simply not be stored in a consistent manner.  For example, 
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some providers may document a diagnosis using structured data and others may 
document via dictated textual notes only.  The CRS provides for a statistically unbiased 
comparison of a new test.  No statistical manipulations are required. 
 
Statistical Adjustment for Reference Standards  
with Known Error Estimates 
 In the case where there are imperfect reference standards with quantifiable error, 
there are statistical methods to adjust the sensitivity and specificity metrics for the new 
test.  Staquet’s equations 5 estimate the sensitivity and the specificity of a new test when a 
reference standard is imperfect but with known sensitivity and specificity and the new 
test and the reference standard are otherwise independent.  With reference to Table 5.2, 
the equations are   
 
 SENSITIVITY NEW TEST  =  (A + C) specificityRS  – C /  
 Equation 5.1 
                    N (specificityRS – 1) + (A + B) 
 
 SPECIFICITY NEW TEST  = (B + D) sensitivityRS  – B / 
 Equation 5.2 
      N (sensitivityRS) – (A + B) 
 
  
 The equation for sensitivity was given in Equation 2.8, and the equation for 
specificity in 2.9.  Staquet’s adjustment can be applied to either the sensitivity or the 
specificity or both.  Table 5.3 shows a hypothetical confusion matrix for a new test for a 
disease with 10% prevalence with the assumption that the reference standard is perfect.  
Table 5.4 shows the adjusted specificity under the assumption that the sensitivity of the 
reference standard was 85% but the specificity was perfect.  The cell contents of Table 
5.4 show the logic and the adjusted specificity of the effect of Equation 5.2 on Table 5.3.  
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Since the specificity of the reference standard was perfect, the sensitivity was not 
adjusted, as follows from Equation 5.1. 
  Application of Staquet’s adjustment has often been reported in the 
literature and was recently reported to be the preferred adjustment when contrasted with 
two other methods.6 
 
Reference Standards for Asthma 
Diagnosis of Asthma 
 An expert panel, commissioned by the National Asthma Education and 
Prevention Program  Coordinating Committee and coordinated by the National Heart, 
Lung, and Blood Institute of the National Institutes of Health, developed guidelines for 
asthma assessment, treatment and control.7  They defined asthma as a “common chronic 
disorder of the airways that is complex and characterized by variable and recurring 
symptoms, airflow obstruction, bronchial hyperresponsiveness, and an underlying 
inflammation.”  Airway obstruction or narrowing, with subsequent airflow interference, 
is the dominant event leading to the typical clinical symptoms:  wheezing, breathlessness, 
chest tightness, cough and mucous production.  The bronchoconstriction may occur 
quickly, in response to variety of allergens or irritants.  These symptoms require and 
respond to bronchodilator therapy.  Airway inflammation is variable in intensity, cellular 
biology, and response to therapy and may distinguish asthma subtype phenotypes.  As the 
disease progresses, swelling of the airways, hypersecretion of mucus and structural 
changes may occur and may not respond to treatment.  Permanent structural changes are 
associated with a progressive loss of lung function. 
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 What causes asthma?  The complex disease has been characterized by abnormal 
immune system physiology, genetic predisposition, higher frequency among women in 
adult onset asthma, allergies and/or exposure to allergens, and certain respiratory viruses.  
Less well established environmental associations include tobacco smoke, air pollution, 
occupations, and diet.  Current treatment can control symptoms but not prevent 
progression to the individual’s underlying severity of asthma.  In the opinion of the 
Expert Panel, there is insufficient evidence to recommend any specific strategies to 
prevent the development of asthma. 
 The Panel provided recommendations to establish a diagnosis of asthma.  The 
clinician should assess for episodic symptoms and partially reversible airflow obstruction 
and exclude alternative diagnoses.  Methods to establish the diagnosis are detailed 
medical history and physical exam focused on the upper respiratory tract, chest, and skin.   
Spirometry is required to demonstrate obstruction and assess reversibility.  Reversibility 
is determined either by an increase in forced expiratory volume of ≥12% from baseline or 
by an increase ≥10% of predicted forced expiratory volume after inhalation of a short-
acting bronchodilator.  Additional studies should be performed as necessary to exclude 
alternate diagnoses. 
 In primary care, asthma may be suspected based on symptoms and history.  
Patients presenting with symptoms of airway obstruction are uncomfortable, and the 
provider may try drug therapy to open their airways.  The suspicion of asthma may not be 
resolved in the medical record. Even if the trial is successful symptomatically, a reliable 
diagnosis of asthma should be supported by spirometry.  A lack of objective testing and 
follow-up to determine asthma according to practice guidelines has been described.8-10  
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Incorrect diagnosis of asthma was studied in several European primary care settings.11-14  
A substantial rate of misdiagnosis of COPD as asthma among those greater than forty 
years of age has been reported.15 Airway obstruction of unknown etiology may be 
diagnosed as ‘reactive airway disease’ and treated with the same medications as for 
asthma.  This nonspecific diagnosis may prevent an appropriate workup to determine if 
the adult patient has asthma.16, 17 
 
Gold Standard for Asthma 
 The gold standard for asthma diagnosis is, by definition, the expert consensus 
criteria to diagnose asthma.7  The problem with the gold standard was described in a 
verification study of administrative disease codes to identify pediatric asthma cases using 
a gold standard based on the Canadian Asthma Consensus Report as reflected in the 
medical record.  The criteria “had to be modified to reflect the cursory level of 
information available based on chart abstraction.”18  Some studies claim the acceptance 
of encounter diagnosis codes as reference standards.19, 20  The Problem List has been used 
as a reference standard.  Others have used methods of inferring a diagnosis of asthma 
from the clinical documentation.  
 
ICD-9 based reference standard 
 The ICD-9-CM category ‘493 Asthma’ and all subclassifications were used in the 
reported reference standards for asthma.  The ICD-9-CM Official Guidelines for Coding 
and Reporting 21 address the overlap in COPD, asthma and bronchitis.  Generally, the 
coding should follow the terms that were documented by the treating clinician.  The 
guidelines contain some arbitrariness for coding acute exacerbations of asthma comorbid 
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with chronic obstructive bronchitis or COPD as the primary code, while the bronchitis or 
COPD would be primary in a nonacute episode.  The ICD-9-CM index defines ‘Asthma, 
unspecified’ as an asthma subclassfication.  Coders may use ‘493.9’ to code ‘reactive 
airway disease’ in adults.  There is inherent uncertainty in the ICD-9-CM codes as a 
reference standard for asthma. 
 Three ICD-9-CM algorithms to ascertain asthma among adult patients using 
ambulatory ICD-9-CM codes were considered for this study.  Blais et al.22 validated 392 
family practice subjects coded as asthma in the ambulatory, fee-for-service billing 
records against provider documentation.  They estimated that approximately 77% of the 
ambulatory asthma diagnoses in the population-based billing system were provided by 
family physicians.  Sensitivity was 85.5% and specificity was 88% for at least two 
asthma codes in a one-year period.  Lix et al.23 validated 529 subjects coded as asthma in 
ambulatory and inpatient encounters against population-based health surveys.  Sensitivity 
fell between the 95% confidence interval from 43.9% to 51.3%.  Specificity fell between 
97.3% and 98.3% for algorithms for at least two ambulatory or one inpatient asthma code 
in a five-year period.  Cases identified by inpatient-only codes contributed little to the 
population studied (0.1%). 
 Specificity was the important metric for the components of the composite 
reference standard developed for this study.  The specificity may have been 
underestimated in the Blais study.  They discussed the limitation of incomplete medical 
documentation and did not report the exact statements required to substantiate a diagnosis 
of asthma.  At face value, it appears they required a diagnostic statement, which others 
have found to be insufficient.  The Lix study validated the billing claims by the patient’s 
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independent report of having asthma in a population-based survey in the coverage area.  
In that context, the low sensitivity is not surprising, as patients may not have had an 
asthma-related visit during the five years or the asthma may have been comorbid with 
and coded as other respiratory illness.  The rigorous study investigated several algorithms 
over varying time periods.  The five-year period was consistent with the duration of 
evidence used for the other components of the reference standard for this study.  An  
algorithm requiring two asthma codes was substantiated by Pacheco et al.,10 who found 
that at least two asthma-related events were required to accurately classify asthma 
patients.  The Lix algorithm for two visits over five years was selected as the reference 
standard for ICD-9-CM codes for the current study. 
 
Problem List 
 Although Problem List in the EHR is known to be incomplete, it has been shown 
to be reliable at >98% specificity.24, 25  Szeto et al.25 studied the accuracy of the 
ambulatory Problem List compared to chart review for 148 patients attending a general 
medicine clinic at a Veterans Administration (VA) hospital.  Sensitivity ranged from 42 
to 81%, while specificity ranged from 98 to 100%.  The Problem List has been used as a 
reference standard for positive disease in recent studies.26-28  An algorithm to identify 
asthma cases for genomewide association studies in the Electronic Medical Records and 
Genomics (eMERGE) network29 described the Problem List codes for asthma as a 
medical diagnosis of asthma.10 
 The literature supports high specificity of an asthma diagnosis in the Problem 
List.  It is consistent with the expected specificity using the ICD-9-CM algorithm selected 
for this study.  Further, and more importantly, the uncertainties of the asthma diagnosis 
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have been noted.  A coded entry for asthma in the Problem List may be incorrect by 
validation standards, but asthma may have been suspected at some visit and used for 
treatment decisions by the provider.  In addition, notation in the EHR Problem List is 
considered part of the legal medical record. 
 
Expert Review of Clinical Documentation 
 Various methods to review the clinical documentation for an asthma diagnosis 
have been reported.  Wilchesky et al.30 used trained study personnel to review a five year 
period in each chart and record whether asthma, as well as 25 other medical conditions, 
were present or absent.  Blais et al.22 reported study nurse review of the chart for a 
diagnosis of asthma.  Neither reported further on the words or conditions constituting an 
asthma diagnosis.  Three studies published criteria to determine asthma from the clinical 
documentation as shown in Table 5.5.18, 31, 32  Review of clinical documents is time 
consuming, and the cost of labor can be high.  Only one of these studies18 used physician 




 Text mining methods were used to limit the number of cases requiring expert 
review of the clinical documentation.  Cohen and Hersh33 described text mining as a way 
to examine the relationships of specific information both within and between documents.  
Text mining techniques used in the current study were information extraction, 
specifically named entity recognition, and data mining.34  Named entity recognition 
identifies the terms of interest in the text.   Named entity recognition can be difficult to 
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accomplish, given that the terms may have multiple meanings, may consist of multiple 
words and may be misspelled.  Misspellings in the clinical documentation are reportedly 
in the range of 10%.35  In the current study, the named entities searched for a direct 
mention of ‘asthma’ in the clinical documents were singular terms and rarely used with a 
different meaning.  In text mining, conventional data mining methods may be applied to 
text features.  A text feature of interest for the current study was the frequency of 
documents having a named entity for asthma for each subject.  The Oracle data mining 
manual presented the use of frequencies of named entities to characterize documents and 
the exploration of their patterns as a common text mining task.36 
 
Methods 
 The study was designed to evaluate the sensitivity and specificity of rules 
generated by a general disease classification framework to identify asthma cases in the 
electronic health record.  The validation set consisted of 992 randomly selected subjects 
from the target population as described in Chapter 1.  The validation subjects were 
assigned as positive or negative for asthma.  A small number of negative cases had 
‘possible’ asthma, which did not meet the criteria for ‘probable’ asthma.  The rules were 
executed against the 2007-2008 EHR data content for the validation subjects.  The 
sensitivity, specificity, and their 95% confidence limits were described for the rules and 
for the union of subjects identified by either the rules or the ICD-9-CM algorithm used in 




Framework Generated Rules 
 The rules to identify new asthma cases were generated using the cohort 
amplification framework.  This associative classification framework was designed to use 
generalized EHR candidate data and processes to generate prediction rules to classify 
multiple health conditions in the EHR.   The framework was described in Chapter 3.  The 
development of the rules used in the current study was presented in Chapter 4.  The rules 
were selected from ten sets of rules generated on separate random samples of the training 
data based on the individual rule’s generality and accuracy. 
 The rules are expressed as attributes or combinations of attributes present in the 
EHR during the two year data mining period, 2007-2008.  The expressed rules represent 
the full rule syntax:  ‘if <attributes> is true, then classify as an asthma case’.  The rules 
are shown in Table 5.6. 
 
Validation Set 
 The validation set (n=992) were randomly selected from the target population 
described in Chapter 1 and were not used in the development of the rules.  The validation 
set were annotated as probable asthma cases or negative for asthma.  The validation cases 
were classified from the available coded evidence for disease in the electronic health 
record as well as expert review of the clinical documents to determine additional 
probable asthma patients that may not have been coded as such.  The negative group 
included those with suggested evidence not meeting the coded standards or the 
documentation criteria (Table 5.5).  The validation set was created and classified before 
the rules were executed.  The rules were executed against data for subjects in the 




Composite Reference Standard for the Study 
 The three components of the composite reference standard (CRS) for positive 
disease were Problem List codes, ICD-9-CM codes, or statements indicating asthma in 
the clinical text documents as interpreted by physicians expert in the diagnosis of asthma.  
CRS negative disease was determined if there was no coded evidence, and either 
physicians determined asthma was not probable from clinical documentation or asthma 
was not mentioned more than once in five years of clinical notes.  The composite 
reference standard is shown in Table 5.7.   
 The validated ICD-9-CM based algorithm used was two ambulatory visits or one 
inpatient visit, including emergency department, over a two year period, 2007-2008.23  
Either the ICD-9-CM based evidence or an active coded Problem List entry for asthma 
determined a positive case, but did not resolve whether the case was negative.  The 
‘Resolver’ was the Clinical Text Documentation.  Assignments were made to probable or 
negative asthma status based on statements about asthma in clinical text documents 
stored for study patients in the Intermountain Enterprise Data Warehouse (EDW) over a 
five-year period, 2004-2008. 
 A text mining approach was used to identify clinical documents with mentions of 
asthma terms and to develop a probability-based classifier to distinguish the most likely 
cases for further manual review to identify asthma cases without coded evidence.   
Details of the development and verification of the text mining approach are described in 
Appendix A.  The result was a simple Bayes rule classifier based on the total number of 
clinical documents with mentions of asthma, including ten variations of the term and its 
common misspellings, per subject over a five year period.  The model demonstrated a 
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probability of 1.3% that a subject with zero or one documents containing the ten asthma 
terms was likely to have asthma.  It was developed on 10,448 random subjects from the 
target population described in Chapter 1.  The Bayes negative asthma status prediction 
model is shown in Table 5.8.  Verification of the model’s prediction of negative asthma 
status was conducted by manual review of a convenience sample of 160 test subjects 
(2%) with zero or one clinical documents containing asthma terms.  The verification 
process used a liberal interpretation of a single probable asthma statement as an error.  
The error rate was 2.5%. 
 The ‘negative asthma status’ prediction model was populated with data from the 
validation set with similar results (Table 5.9).  Thirteen percent of the predicted negative 
asthma status validation subjects’ clinical documents were reviewed by an independent 
nurse reviewer.  Clinical document review methods are described in Appendix B.  The 
error rate was 1%.  Seventy-eight percent of the validation sample was covered by the 
negative asthma status prediction model, with an estimated chance of falsely labeling a 
positive case as a negative one of 1-2.5%.  Assuming the highest error estimate (2.5%) 
and using Staquet’s adjustment, the composite reference standard has an estimated 
sensitivity of 87% (Table 5.10).  Assuming the lowest estimate (1%), the estimated 
sensitivity is 94% (Table 5.11). 
Cases in the resolver component of the composite reference standard with more 
than one document with an asthma term (n=98) were manually reviewed (Appendix B) in 
two stages.  First, expected mentions among negative cases were screened out (n=52).  
These consisted of hypothetical statements about the disease such as “at risk for”, 
references about someone else and the disease such as in “family history of”, or 
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assertions that the patient did not have asthma.37, 38  Cases with a statement concerning 
the possibility of a diagnosis or history of asthma were reviewed by physician experts 
(n=46).  Of these, 28 subjects were judged as probable asthma cases.  For purposes of this 
study, the composite reference standard was assumed to have perfect specificity.  Codes 
or statements defined as positive for the reference standard were accepted as a provider’s 




 The sensitivity and specificity with 95% confidence intervals were computed for 
the classification of the validation data using the framework rules.  Standard algorithms 
for sensitivity (Equation 2.8) and specificity (Equation 2.9) were used, reporting both 
adjusted and nonadjusted specificity, and the 95% confidence intervals were computed 
using the Wilson score method.39  This sensitivity was also computed and reported for the 
cases covered by either the framework or the validated ICD-9-CM algorithm.  The 
specificity was not affected by the ICD-9-CM algorithm.  The ICD-9 algorithm was a 
component of the positive reference standard, and its absence did not determine a 
negative case.  The purpose of the joint sensitivity statistic was to evaluate the 
contribution of the framework rules beyond cases known by a validated ICD-9-CM based 
identification algorithm.   
 Frequencies of occurrence of the single attributes that formed the rules as well as 
some interesting profile characteristics among composite reference standard positives and 
negatives and true positives, false negatives, true negatives and false positives classified 
by the framework rules were described.  Differences in the frequencies between CRS 
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positives and negatives were calculated with 95% confidence intervals using 
Newcombe’s method.  Confidence intervals that include zero are not statistically 
significant differences.40  Ratios of the frequencies, also known as risk ratios, with 95% 
confidence intervals based on the Cox-Hinkley-Miettinen-Nurminen method,41  were also 
calculated for some asthma comorbidities. 
 
Results 
 The sensitivity of the framework generated rules was 54% with 95% confidence 
interval 46.0% to 62.4%.  The most conservatively adjusted specificity, under the 
assumption that the error in the negative asthma prediction model was 1%, was 97.1% 
with 95% confidence interval 95.8% to 98.1% (Table 5.12).  When cases identified by the 
ICD-9 algorithm of two asthma codes over five years were combined with cases 
identified by the rules, the sensitivity was 83% (76.2% to 88.6%) (Table 5.13).  The 
specificity was unchanged.  Using the ICD-9 algorithm alone, the sensitivity was 70% 
(62.2% to 77.3%) (Table 5.14).  The rules alone did not identify as many CRS positive 
cases as two ICD-9 codes over five years alone.  However, it did contribute an additional 
13% of the CRS positive cases.  The difference in the proportions contributed by both 
versus by ICD-9 codes alone was statistically significant, with the 95% confidence 
interval of the difference from 3.1% to 22.7%. 
 Table 5.15 shows the sequential rules, the number of true positives (TP) and false 
positives (FP) covered, and the Positive Predictive Value (PPV) of each rule.  Subjects 
often met multiple rules.   Table 5.16 shows the number of subjects that met each 
combination of rules, with no distinction as to the classification accuracy.  This shows 
how the rules clustered.  The first covering rules are the focus of analysis because they 
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perform the classification.  Table 5.15 shows that two of the nine rules covered no CRS 
positives, one had no unique coverage, and five rules had poor (< 70%) positive 
predictive value on the validation data.  
 The diagnosis of asthma may be confounded by other respiratory problems that 
may be  comorbid with asthma or mistaken as asthma:  bronchitis, sinusitis, rhinitis and 
chronic airway obstruction (COPD).7  All of these conditions were found to be more 
frequent among the CRS positive subjects (Table 5.17).   Since similar medications may 
be used as well, frequencies among these respiratory problems among the true positive 
(TP), false negative (FN), true negative (TN), and false positive (FP) rule classifications 
were explored and are shown in Table 5.18.  Bronchitis and COPD appeared most 
frequently among the incorrect classifications.  Sinusitis, acute bronchitis and allergic 
rhinitis occurred with false negative classifications more frequently than false positives.  
Chronic bronchitis occurred equally with both.  COPD occurred with false positive 
classifications more frequently than false negatives. 
 Differences in demographic, health care encounter and EHR documentation 
characteristics between the composite reference standard (CRS) positives and negatives 
are shown in Table 5.19.  Characteristics with no statistically significant difference are 
italicized.  There is virtually no difference in the ages.  There are more females (64.5% 
vs. 53.5%) in the positive group than the negative.  The positives have more obesity 
(7.2% vs. 5.2%) and more pain (14.5% vs. 10%), as documented by ICD-9 codes, but 
neither was a statistically significant difference.  Positives appear to have more health 
problems as evidenced by statistically significant differences in those with more than six 
ambulatory provider visits in one year (58% vs. 40.7%) and at least one emergency 
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department visit over two years (31.2% vs. 18.9%).  Positives were more likely to have a 
populated Problem List (79% vs. 66.3%) or Medication List (97.8% vs. 90.6%) in the 
electronic health record.  Since all subjects had at least two visits to Primary Care during 
the study period, where providers typically use the Medication and Problem Lists, this 
may reflect more patients among the negatives with acute or short term problems, such as 
the common cold or health checkups, that providers have no need to track in the Problem 
List.  Similarly, the negatives may be less likely to have any prescribed medications.  The 
CRS asthma-positive group were no older, but were generally less healthy and more 
likely to be female than the CRS asthma-negative group.   
 Table 5.20 shows how these characteristics aligned with the classification 
outcomes:  TP, FP, TN, and FN.  Obesity documented in ICD-9 codes was associated 
more frequently with true and false positive classifications compared to the overall 
classification distribution.  ICD-9 codes for pain, more than six health ambulatory 
provider visits in one year, and at least one emergency department visit over two years 
were associated with true positive predictions.  Female gender was associated with false 
negative classifications.  
 The associative classification metrics used to generate the rules may also provide 
new knowledge about the targeted disease or condition.  Some previously described 
associations – allergies, eczema, gastric esophageal reflux disease (GERD),42 sleep apnea 
7
  - and unexpected associations between asthma and other medical conditions were noted 
in the training data.  Associations that persisted in the validation data between CRS 
positive and CRS negative subjects are shown in Table 5.21.   The first group contains 
GERD and allergy-related attributes.  These attributes all had statistically significant 
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differences in their frequencies between CRS positives and negatives.  They also had risk 
ratios, the ratio of proportions, with 95% confidence intervals greater than unity.  The 
second group contains sleep disorder, often related to obesity (Table 5.19), along with 
diabetes, hypertension, and cardiac problems.  Diabetes and hypertension were not found 
to be highly associated with asthma in either the training data or the validation data, but 
they were included here because they are also known to be related to obesity and cardiac 
problems.  Both cardiac symptoms and cardiologist visits were significantly higher 
among CRS asthma subjects even though their age was no different from the CRS 
negative subjects.  The third group shown is arthritis and fibromyositis or neuritis ICD-9 
codes along with a higher frequency of narcotic analgesics use.  The ICD-9 codes defined 
by the National Arthritis Workgroup43 were combined to form the arthritis grouping.  
ICD-9 729 covers unspecified rheumatism, fibrositis, myalgia, myositis, neuritis and 
other inflammatory conditions of related tissues.  This was interesting because 
fibromyalgia syndrome – characterized by arthritis, generalized muscular pain, sleep 
disorders, and other associations discovered among the asthma subjects – also occurs 
more often in women but has not been described as a comorbidity with asthma.  The CRS 
positive asthma group had a significantly higher proportion of women (64.5% versus 
53.5%), as described above.  The use of narcotic analgesics could not be explained by 
any other associations in the data other than the pain inherent in the inflammatory joint 
and muscle conditions included in this group.  The fourth group shows associations 
among an ICD-9 code for nonspecific findings on imaging and other diagnostic 
procedures, and the use of antipsychotic medications.  The use of antidepressant 
medications was higher among the CRS positive subjects, but the stronger association 
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was the combination of antidepressant and antipsychotic agents.  These are often used 
together in more severe cases of clinical depression. 
 
Discussion and Conclusions 
 The accuracy results showed that the cohort amplification process was successful 
in learning patterns among a standard EHR-based data set using exemplars of a target 
cohort to identify additional members of the cohort directly in the EHR.  Asthma was one 
of the first medical conditions chosen to test the cohort amplification process.  A fair 
amount of difficulty in identifying asthma cases using retrospective EHR data was 
described in this chapter.  The inaccuracy of the classification rules reflect some of the 
same problems:  uncertain diagnoses, misdiagnoses due to confounding respiratory 
problems, similar treatments and medications used in related respiratory problems, and 
the episodic nature of the disease itself.  Nonetheless, the rules learned on exemplar data 
of subjects with asthma noted in the Problem List were useful in identifying additional 
asthma subjects beyond those that could be identified using the ICD-9 codes in the EHR. 
 Further analysis of the number of subjects that met each rule demonstrated poor 
predictive value by five of the nine rules (Table 5.15).  This could be due in part to an 
incorrect reference standard.  The reference standard developed for asthma was flawed by 
the same problems in discerning true asthma cases from retrospective EHR 
documentation, even when interpreted by experts.  In a real-world application of the 
cohort amplification framework, the false positive and false negative cases may be 
further reviewed by experts.  Those resources were beyond the scope of this study.  
Reference standards for validation of retrospective case identification methods for 
secondary uses of the EHR are a difficult problem.  If a good reference standard exists, it 
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implies there is already a case identification method.  As the expectations for secondary 
use expand with the wider adoption of the EHR in practice and the promise of 
standardized health care data, computer-based methods to ascertain cases must be used.  
Perhaps ‘triangulation’ strategies will prove successful, in which machine learning and 
classification methods use coded data and natural language processing to compare 
evidence from multiple sources in the EHR and focus expert review on the marginal 
cases.  A repository of such evidence may also prove useful so it does not have to be 
rediscovered and clinicians may authenticate or reject a machine generated disease label.  
 Another plausible reason for the poorer predictive value than was generated from 
the training data is the variation that may exist among exemplars as compared to the 
population of true cases in the EHR.  In this study, the asthma exemplars were drawn 
from those coded in the Problem List.  Frequencies of rule component attributes were 
checked between CRS positive cases that were also coded in the Problem List (PL) 
(n=60) versus the entire group (n=138).  The largest differences found were a lower 
proportion of female subjects (57% versus 64%) and less use of albuterol (17% versus 
25%) in the PL group.  Smaller differences in other rule components and a similar 
distribution of differences in demographic and comorbidity characteristics showed the 
expected sampling variation and perhaps some bias of an exemplar cohort.  
Unfortunately, we cannot assess the differences before the rules are generated so two 
remedies are suggested.  First, the standard processes for knowledge discovery from 
databases include refinement and iteration of the machine-learning steps.  In actual 
application, one may correct for the less useful rules or biases discovered in the training 
data and repeat the rules generation.  Secondly, more conservative criteria for the 
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selection of rules was used in the cohort amplification rule pruning methods than in the 
classic methods.  With the pattern-learning focus on disease processes described by 
highly related EHR data, the pruning constraints may need to be tightened.  For example, 
for the rules used in this study, a minimum of five training cases had to be covered by a 
rule or it was pruned.  In addition, rules were pruned if the positive predictive value on 
the training data was less than 70%.   The results of this study suggest that differences in 
the exemplar and target populations as well as random variation may necessitate stricter 
pruning criteria and thus more general rules.  
 The analysis of false positives and false negatives among the subjects with 
associated respiratory problems was useful.  There did not appear to be remarkable 
differences in the distribution of classification outcomes for subjects with sinusitis or 
allergic rhinitis.  However, bronchitis, in particular chronic bronchitis, and chronic 
obstructive pulmonary disease (COPD), with or without comorbid asthma, resulted in 
less accurate classification by the rules.  These conditions are known to be confounders in 
asthma diagnosis and case finding.  For some research purposes, cases with these 
complications have been excluded.10  For many purposes, such as clinical quality 
improvement, they may be important to capture because patients may be at higher risk.  
In this study, less than 5% of the validatation cohort had evidence of chronic bronchitis or 
COPD.  These may need focused expert review or development of a classifier using 
specific EHR data and methods relevant to this problem. 
 Other demographic, general health and comorbidity characteristics presented in 
the results may provide knowledge to improve the identification of cases.  The rules may 
be refined and reiterated based on the additional domain information directly or further 
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domain analysis may be inspired.  A suggested increase in false positive classifications 
correlated with the ICD-9 code for obesity might invoke further review of the data for 
these subjects.  The same may be said for the higher frequency of female subjects with a 
false negative classification.  For purposes of this study, a benefit of the associative 
classification method was shown.  The frequencies of all attributes and attribute 
combinations that are used to form the rules are exposed in the training data.  In this 
study, selected attributes of interest in the training data were generated and described for 
the validation set to help understand the classification outcomes. 
 Another benefit of the associations exposed by this classification method is the 
potential for serendipitous knowledge discovery.  In this study, focused on the 
development of rules to identify asthma, several associations that appeared in the training 
data and persisted in the validation data were described.  These characterized some 
known comorbidities of asthma, such as gastric reflex disease, sleep disorder and 
symptoms of skin (allergic reactions).  However, associations with cardiac problems, 
arthritis and other inflammatory conditions of the connective tissue have not been 
described as comorbidities with asthma.  They may not be.  The associations discovered 
among existing data do not imply causality nor rule out a shared dependency on some 
other causal factor.  However, the associations reported in Table 5.21 were originally 
noted in the training data and persisted in the validation data as statistically significant 
associations among asthma-positive cases compared to asthma-negative cases.  Further 





Table 5.1  General Composite Reference Standard 





















Table 5.2  Reference for Equations 5.1 and 5.2 
 
  Reference Standard 
(RS) 
+               - Total 











Total   N 
Sensitivity  TP/(TP+FN)   




Table 5.3  Unadjusted Sensitivity and Specificity   
 
 Reference Standard 
(RS) 
+               - Total 
New Test        +  90  40 108 
- 10 860 892 











Table 5.4  Adjusted Specificity from Table 5.3 
                 Given SensitivityRS=.85, SpecificityRS =1 
 
  Reference Standard 
(RS) 
New Test         +               0.15 Pos 
Missed 
- Total 
 +  90 (-16) 24 130 
 - 10  (-2) 858 870 




















2 or more asthma care (AC) visits x
Single AC visit and prior history x
Single AC visit for active symptoms
SingleAC visit and response to meds x
Possible
Patient reported history only x
Uncorroborated emergency diagnosis
Suspected with no clear resolution x
Twiggs Definite
Clinical dx and 2+ visits acute wheezing x
Possible
Asthma symptoms + history allergy, wheezing x
To 2 visits for wheezing x
1 visit wheezing + risk factor x






Table 5.6  Asthma Identification Rules 
 
Rule 
Number Rule Data Source
1 Salmeterol Med ingredient
2 Glucocorticoid AND Albuterol Med class
3 Leukotriene Receptor Antagonist Med class
4




Other_Pulmonary_Procedure Med class, CPT aggregate*
6 Albuterol AND Female Med ingredient, Demographic feature
7
Allergy_Specialist_Visit AND 
Other_Pulmonary_Procedure Visit feature, CPT aggregate
8 Albuterol AND Abnormal_CBC Med ingredient, Lab abnormality
9
Albuterol AND 
Urinalysis_by_dip_stick Med ingredient, Lab order
* Breathing capacity test, airway inhalation treatment, pulse oximetry, monoxide 




Table 5.7  Diagram of the Composite Reference Standard 
 


















































0-1 103 0.010 0.013 8037 0.769 0.987 0.779
2+ 1057 0.101 0.458 1251 0.120 0.542 0.221































0-1 8 0.008 0.010 784 0.783 0.990 0.798
2+ 102 0.102 0.510 98 0.098 0.490 0.202




Table 5.10  Adjusted Sensitivity Composite Reference 








Prob Pos | 

















Table 5.11  Adjusted Sensitivity Composite Reference 








Prob Pos | 





















54.3 % 46.0 - 62.4
96.6







Specificity Adjust. 2.5% Error CRS
95% Confi- 
dence Interval
*The most conservative adjustment was used.













































Table 5.15  First Ordered Rule Met by True Positives and False Positives  
















PPV   
(%)
1 Salmeterol 41 6 87.2
2 Glucocorticoid AND Albuterol 17 2 89.5
3 Leukotriene Receptor Antagonist 5 2 71.4
4
Beta Adrenergic Agent Not Albuterol 
or Salmeterol 3 3 50.0
5
Glucocorticoid AND 
Other_Pulmonary_Procedure 5 6 45.5
6 Albuterol AND Female 3 7 30.0
7
Allergy_Specialist_Visit AND 
Other_Pulmonary_Procedure 1 0 100.0







Table 5.16  Number of Subjects Meeting Each Rule 
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Table 5.17  Respiratory Comorbidities 







Number of Subjects 138 854
ICD 461_Acute_sinusitis 27.5 20.0 7.5 0.2 15.9 1.4
ICD 466_Acute_bronchitis 26.1 8.7 17.4 10.5 25.5 3.0
ICD 473_Chronic_sinusitis 5.1 2.2 2.8 0.0 7.9 2.3
ICD 477_Allergic_rhinitis 21.0 8.2 12.8 6.5 20.5 2.6
ICD 490_Bronchitis_NOS 11.6 5.0 6.6 1.9 13.1 2.3
ICD 491_Chronic_bronchitis 4.3 1.1 3.3 0.8 8.1 4.1

























Table 5.18  Classification Frequencies of Subjects with Associated Respiratory  

















ICD 461_Acute_sinusitis 209 12.4 3.8 78.0 5.7
ICD 466_Acute_bronchitis 110 21.8 8.2 59.1 10.9
ICD 473_Chronic_sinusitis 26 19.2 0.0 73.1 7.7
ICD 477_Allergic_rhinitis 99 21.2 4.0 66.7 8.1
ICD 490_Bronchitis_NOS 59 22.0 5.1 67.8 5.1
ICD 491_Chronic_bronchitis 15 20.0 20.0 40.0 20.0




Table 5.19    Demographic, Encounter and EHR Documentation Characteristics 







Number of Subjects 138 854
Age Greater Than 47 57.2 57.1 0.1 -8.8 8.9
Female 64.5 53.5 11.0 0.9 18
ICD 278 Obesity and other alimentation 7.2 5.2 2.1 -1.5 8
ICD9 codes for pain* 14.5 10.0 4.5 -1.4 10.8
6+ Ambulatory Provider visits/year 58.0 40.7 17.3 8.0 25.5
Emergency department visit 31.2 18.9 12.3 4.5 20.7
Populated Problem List 79.0 66.3 12.7 4.8 19.8
Populated Medication List 97.8 90.6 7.2 2.5 9.4























Table 5.20   Classification Frequencies of Subjects by Demographic, Encounter  


















Age Greater Than 47 567 8.1 3.4 82.8 5.8
Female 546 8.1 3.3 80.4 8.2
ICD 278 Obesity and other 
alimentation 54 14.8 5.6 75.9 3.7
ICD9 codes for pain 105 13.3 0.9 79.7 5.7
6+ Ambulatory Provider Visits 
in One Year 428 12.6 3.7 77.6 6.1
Emergency department visit 204 13.7 3.4 75.3 7.3
Populated Problem List 675 9.2 3.7 80.1 7.0
Populated Medication List 909 8.3 3.2 82.0 6.6














Significant Comorbidity & 
Symptom Associations
ICD 530 GERD or Proton 
pump inhibitors 43.5 23.9 11.1 28.4 1.4 2.3
ICD 787 Symptoms 
digestive system 20.3 12.8 4.0 18.0 1.1 2.3
ICD 782 Symptoms of skin 26.1 10.7 8.4 23.5 1.7 3.4
Allergy Specialist Visit 6.5 0.6 2.8 11.3 4.0 31.2
ICD 327 Organic sleep 
disorder 13.8 6.9 1.6 13.7 1.2 3.2
ICD 250 Diabetes mellitus 17.4 14.2 -2.8 10.7 0.8 1.8
ICD 401 Essential 
hypertension 42.8 35.5 -1.80 15.7 1.0 1.5
CARDIOLOGY Visit 22.5 14.3 1.5 16.1 1.1 2.2
ICD 785 Symptoms cardio 
system 15.2 6.8 3.0 15.5 1.4 3.5
Arthritis (ICD 715, 716, 719, 
726, 727, 728)** 48.6 33.0 6.7 24.3 1.2 1.8
ICD9 729 Fibromyositis, 
Neuralgia, CFS 23.9 15.9 1.1 16.1 1.1 2.1
Narcotic Analgesics 48.6 33.5 6.4 24.1 1.2 1.7
ICD 793 Nonspecific 
abnormal findings 12.3 7.4 0.4 12.0 1.0 2.7
Antipsychotic meds 18.1 10.8 1.1 14.6 1.1 2.5
Antipsychotic & 








Proportions      
95% Confi-   
dence Interval 
Ratio of 
Proportions*      








* Ratio of Proportions also known as Relative Risk




Table 5.22  Document Types Used in Text Mining 






%  Cases  





%  Case s 










%  Cases 
w/ 1  or 
More 
Docu- 
m ents of 
Type
% Cases 
with  1 or 
Mor e 
D ocu- 
m ents  of 
Type w/ 
Entities 
P rogress No te 1075 100 .0 90 .7 4584 99.5 25.1
Lab An notation 836 77 .7 0 .4
XR Chest 2 Views Fron tal Lat 606 56 .3 3 .9 1384 30.0 0.3
Em ergency D epa rtment Report 599 55 .7 33 .1 1807 39.2 2.1
Lette rs 583 54 .2 3 .2 2184 47.4 0.1
Urgent Care  No te 561 52 .1 39 .0 2004 43.5 9.7
History an d Physical Repo rt 502 46 .6 20 .7 1701 36.9 1.8
S urgical Pathology Report 501 46 .6 0 .0
Em ergency D ept Vis it Note 487 45 .3 9 .9 1284 27.8 0.0
Ra dio logy Anno tatio n 463 43 .0 0 .5 1506 32.7 0.0
Operativ e Report 448 41 .6 0 .3
P hysic ian  Order 438 40 .7 0 .9 1550 33.6 0.0
Disch arge Summary 345 32 .0 10 .4 903 19.6 0.0
En doscopy Pro cedure Repo rt 342 31 .8 2 .6 1287 27.9 0.0
Co nsultation Report 310 28 .8 8 .1 975 21.1 1.2
X/Ray Report 275 25 .5 0 .6 687 14.9 0.0
Outside M edical Inform ation 243 22 .6 0 .0
Fo rmal Le tter 240 22 .3 2 .4 735 15.9 0.1
Echo Repo rt 231 21 .4 0 .8
Laboratory Report 196 18 .2 0 .0
P ulm on ary Func tion Study Rep 192 17 .8 1 .2
Ox imetry Report 166 15 .4 1 .1 330 7.1 0.0
XR Chest Fron tal 1 V iew 152 14 .1 0 .2 377 8.1 0.0
Bone M ineral Density (D EX A) 139 12 .9 0 .7 498 10.8 0.0
P olyso mn ography Report 110 10 .2 3 .3 231 5.0 0.1
M RI Bra in W O W Cnt 103 9 .5 0 .1
Outpatient Clinic Report 102 9 .4 2 .7 376 8.1 0.0
Co mp rehe nsive Eye Exam  Rep 100 9 .3 3 .6 434 9.4 0.0
Add endum  Rep ort 97 9 .0 0 .3
CT Ang io Ch est 88 8 .1 0 .2 138 2.9 0.0
En doscopic Report 86 8 .0 1 .0
History/Physical - Pre-O p Rep 86 8 .0 3 .4 270 5.8 0.0
Ca rdiac Catheter ization Report 77 7 .1 0 .3 212 4.6 0.0
XR Chest 1 View P ortable 75 6 .9 0 .0
NM  Myoc ard S PECT Ex Rest 66 6 .1 0 .0
P rogress No tes - Ortho  Surg 62 5 .7 0 .9 177 3.8 0.0
CLIN ICAL NO TES:   Jan 1, 2004 - Dec  31, 20 08. 
Nam ed  Entities: A STHM A, ASTH MATIC, ASTHMATICU S, ASTHAM , A STHM , 
AS THM AS, ASTHMATICS,  AS THAM A, ATHM A , ASHTMA
Clinical Docum ent Type Evidence Samp le No Evidence Sam ple




Table 5.23  WEKA Bayesian Network Model Annotated for Cumulative Counts 



























0 30 0.003 0.005 5984 0.573 0.995 0.576
1 73 0.007 0.034 2053 0.196 0.966 0.203
Cum 0-1 103 0.010 0.013 8037 0.769 0.987 0.779
2 81 0.008 0.098 746 0.071 0.902 0.079
3 79 0.008 0.228 268 0.026 0.772 0.033
4 80 0.008 0.415 113 0.011 0.585 0.018
5 70 0.007 0.603 46 0.004 0.397 0.011
6 69 0.007 0.711 28 0.003 0.289 0.009
Cum 7+ 678 0.065 0.931 50 0.005 0.069 0.070
7 thru 24 515 0.049 0.912 50 0.005 0.088 0.054
25 + 163 0.016 1.000 0 0.000 0.000 0.016











WHEEZE OR WHEEZES OR WHEEZING OR DYSPNEA 
OR COUGH OR COUGHS OR COUGHED OR COUGHING 
OR BRONCHITIS OR ALLERGIC OR AIRWAY OR BRONCHIAL 
OR BREATHING OR BREATHLESS OR BREATH OR BREATHLESSNESS  
OR ALBUTEROL OR SALMETEROL OR MONTELUKAST 
OR FEV OR SPIROMETRY OR EXPIRATORY 
OR INHALER OR BRONCHODILATOR OR BRONCHODILATER  
OR BRONCHOSPASM OR BRONCHOPROVOCATION 
 
MEDICAL ASSESSMENT TERMS 
P OR ASSESSMENT OR PLAN OR PROBLEM OR PROBLEMS OR PRESENTING 
OR PRESENTS OR PRESENTED OR IMPRESSION OR HISTORY OR DIAGNOSIS 
OR DIAGNOSES OR DX OR CHIEF OR COMPLAINT OR TRIAGE OR STATUS 
OR SUGGESTS OR SUGGESTED OR SUGGESTING 
OR TROUBLE OR TROUBLED OR REPORTS OR REPORTED  
OR INDICATION OR INDICATIONS OR SUSPECT 
OR SYMPTOM OR SYMPTOMS OR FINDING OR FINDINGS 





Text Mining Methods to Predict 
 
Negative Asthma Status 
 
 Approximately 11% prevalence of asthma was expected in the study population.  
Most of the positive cases were identified by coded evidence for asthma, leaving 
approximately 90% of the remaining validation set to be assessed for uncoded cases of 
asthma.  Text mining methods were developed to identify the most likely cases for 
manual review.  The Intermountain Enterprise Data Warehouse (EDW) stores all clinical 
documents for hospital and ambulatory visits.  These are parsed by an Oracle text 
indexing program,44 and each word is indexed.  The process of searching for particular 
words or phrases, called ‘named entities’, is a common method described in the text 
mining literature.33, 45  The frequency of each test subject’s clinical documents having 
named entities for asthma over a five-year period were derived for a test sample 
(n=10,448).  A probability-based classification rule was modeled on the frequencies and 
coded evidence for asthma using machine-learning methods.  A simple Bayes rule 
classifier demonstrated a 1.3% error rate in the prediction of negative asthma on 78% of 
the test cases, having zero or one named entity for asthma over five years.  The result was 
validated on a convenience sample of 2% (n=160), which demonstrated an error rate of 
2.4%. 
 The named entities to represent asthma were based on the UMLS Unified Medical 
Language System® (UMLS)® Metathesaurus® terms for asthma.  The terms may have 
been more expansive but were covered by the words:  ‘ASTHMA’, ‘ASTHMAS’, 
‘ASTHMATICUS’, and ‘ASTHMATIC’.  ‘ALLERGIC BRONCHITIS’ was the only 
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UMLS term not used because  it was not used in the study population.  Six commonly 
occurring misspellings were added:  ‘ASTHAM’, ‘ASTHM’, ‘ASTHMAS’, 
‘ASTHMATICS’, ‘ASTHAMA’, ‘ATHMA’, and ‘ASHTMA’.  These terms were the 
ones used at least 0.01 % (.0001) as frequently as the primary term ‘ASTHMA.’  These 
were the ten named entities used to search the clinical text. 
 All clinical text documents were searched for the named entities over a five-year 
period (2004-2008) for a random sample of study subjects (n = 10,488).  These were 
divided into a subset with coded evidence of asthma (n = 1,075), referred to as the 
‘evidence’ sample, and a random subset of half those with no coded evidence (n = 4,607), 
the ‘no evidence’ sample.  Coded evidence was defined as at least two ICD-9-CM 
ambulatory or one inpatient/ED code or an active Problem List code over the five-year 
period.  There were 1,130 document types used.  Intermountain Healthcare did not have 
standardized document type names, and several types could be functionally similar.  The 
document types with at least one named entity for either sample (n = 161) were reviewed 
for appropriateness of document type and relative density of named entity mentions 
among the no evidence to evidence samples.  Appropriateness was determined by 
whether this was a document type generally authored by providers of healthcare, who 
customarily document either disease status or elicit/request and record patient disease 
history in order to perform their clinical services.  Five types were removed:  ‘Message 
Log Notes’, ‘Nursing Notes’, ‘Lab Req – not a part of the Medical Record’, ‘Mental 
Status Exam’ and ‘Emergency Department Triage Note.’  Message Log Notes may be 
authored by nonclinical staff.  The Emergency Dept Triage Note was a preliminary, 
admitting record and was authenticated as a longer, final Emergency Dept Visit Note.  
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The others were not considered typical sources of diagnostic or patient history 
observations and contained only 1-3 named entity mentions in total. 
 Progress Notes were the most frequently used document type among study 
subjects.  All of the evidence sample and 99.5% of the no evidence sample had at least 
one Progress Note.  Progress Notes usually documented an ambulatory clinic visit.  The 
average number of Progress Notes per case during this period was 22 for the evidence 
sample and 15 for the no evidence sample.  The average number of Progress Notes with 
named entities per case was 10 for the evidence sample and 0 for the no evidence sample.  
Multiple Progress Notes per case gave the most opportunity for the expected mentions 
among negative cases:   hypothetical statements about the disease such as “at risk for”, 
historical diagnosis statements, references about someone else and the disease such as in 
“family history of”, or a negation of the disease diagnosis.37, 38  Among no evidence 
cases, 25.1% had at least one named entity mention in a Progress Note (Table 5.22).  This 
rate was then used as a heuristic measure of the expected density of mentions among no 
evidence cases for a document type.  Samples of cases with document types with a higher 
density than 25% among no evidence cases were reviewed.  Nine document types 
contained templated text or other reasons for a higher density of mentions of asthma 
among noncases and were removed.  There were finally 147 document types used for the 
subject-level counts of documents and named entities.  The document types occurring for 
more than 5% of the evidence sample are shown in Table 5.22, with the frequencies of 
cases having at least one instance of the document type and among those, the frequencies 
of cases having at least one named entity for asthma in that document type. 
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 Next the individual asthma named entity counts were analyzed using attribute 
selection and classification methods in WEKA.46  Two separate random samples (n = 
~10,000) of cases from the study population were generated.  The two samples were used 
for both training and testing of the other.  Document counts and counts of documents 
with a named entity over the five year period, 2004-2008, were computed for each case 
over the 147 document types.  Only one count per document type per day was allowed 
because there were occasional duplicate or redundant document instances in the EDW.  
One count of the total number of documents and one count for documents containing at 
least one named entity for asthma were stored in the study database. The count of 
documents with named entities divided by the count of documents was computed for 
each case as a density function and populated for training cases in the study database.  
The class attribute was coded evidence of disease versus no coded evidence.  The four 
attributes were analyzed in WEKA using the Bayesian network classifier.  The Bayesian 
network classifier was selected for its ability to learn the best structure and expose the 
probability tables.46  Attribute selection methods in WEKA consistently agreed upon the 
named entity count as the best attribute, and the wrapped Bayesian network selection 
method preferred it as a single attribute.  The attributes in the model were reduced to the 
named entity counts and the class (outcome).  The final model was essentially a simple 
Bayes rule classifier. 
 The WEKA Bayesian network model was recreated in Excel to show the most 
predictive discretizations of the named entity counts.  The model is shown in Table 5.23.  
The classifier demonstrated a 1.3% error rate in the prediction of negative asthma status 
on 78% of the cases, having zero or one named entity for asthma.  The result was 
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validated on a convenience sample of 2% randomly selected cases with zero (n=100) or 
one (n=60) named entities.  Of the zero named entities sample, there was one case 
documented as ‘azthma’.  Of the one named entity sample, there were four cases with 
statements of possible asthma.  Asthma status was not further ascertained in the 
validation.  The error rate was 2.4%.   
 Accordingly, for the study composite reference standard, cases requiring 
resolution by review of the clinical documentation were determined negative if they had a 
named entity count of zero or one.  Cases with 2+ named entities were manually 
reviewed if they were not already determined positive by the coded evidence in the 
composite reference standard.  The simplified version of the negative asthma status 





Clinical Document Review Procedures 
 
 The Intermountain Enterprise Data Warehouse (EDW) stores all clinical 
documents for hospital and ambulatory visits.  These are parsed by an Oracle text 
indexing program,44 which stores each word in an index.  The process of searching the 
indexed words for ‘named entities’ is a common method described in the text mining 
literature.33, 45  Three groups of named entities were defined for this study for different 
purposes.  The first was used for both clinical document review and development of the 
negative asthma status prediction model.  The other two were defined for clinical 
document review only. 
 The first group was asthma terms.  The named entities used to represent asthma 
were based on the Unified Medical Language System® (UMLS)® Metathesaurus®.  The 
terms were more expansive but were covered by the words:  ‘ASTHMA’, ‘ASTHMAS’, 
‘ASTHMATICUS’, and ‘ASTHMATIC’.  ‘ALLERGIC BRONCHITIS’ was the only 
UMLS term not used because was not used in the study population.  Six commonly 
occurring misspellings were added:  ‘ASTHAM’, ‘ASTHM’, ‘ASTHMAS’, 
‘ASTHMATICS’, ‘ASTHAMA’, ‘ATHMA’, and ‘ASHTMA’. 
 The second group consisted of terms that describe symptoms, medications, and 
comorbidities associated with asthma.  This group was generated from the literature on 
asthma symptoms, diagnosis and treatment.  The asthma-related terms are shown in Table 
5.24.  The third group consisted of terms used by clinicians in their documentation to 
state assessments, impressions, diagnoses, plans and included almost all direct medical 
care documents.  These terms were found by iterative queries against a set of known 
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clinical documents while adding to the search terms from documents not found.  The 
medical assessment terms are shown in Table 5.24. 
 Reports were developed to query and display variable length snippets of text 
around named entity search terms as well as the full text with the search terms 
highlighted for each clinical document selected.  This enabled fast, direct access to the 
documents and the specific statements in the documents containing the named entities.  
The reports were easily modified and ran in a public domain SQL query application.  
This enabled the nurse reviewers to perform the reviews on their desktop computers with 
no protected health information removed or stored from the EDW repository. 
 A 13% random sample of the 784 validation set subjects having zero or one 
clinical document with an asthma term and not resolved by the coded evidence were 
reviewed.  One experienced nurse volunteer used the asthma-related search terms to 
attempt to find clinical documents for 60 subjects with zero asthma terms.  Two subjects 
had documentation suggestive of asthma but no definitive statement or further evidence.  
For those with an unconfirmed suggestion, a search was done using the medical 
assessment terms to display diagnostic statements.  In this manner, the suspicious 
subject’s full documentation was efficiently displayed in reverse chronologic order.  It 
gave focus to the assessment statements as one line listings and the ability to toggle to the 
complete document with highlighted search terms.  Forty-two subjects with one clinical 
document with an asthma term were similarly reviewed.  For these, the first step was to 
search and review the asthma terms in the one clinical document.  If these statements 
implied a negative asthma status, the subject’s review was negative.  If asthma was 
suggested, the review process continued with the asthma-related terms as described 
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above.  One missed asthma case was ascertained from an asthma diagnosis statement and 
a history of asthma medications. 
 All validation subjects with more than one clinical document having asthma terms 
and not resolved by the coded evidence (n=101) were reviewed.  In the first stage, the 
asthma terms were searched and reviewed as described above.  If these statements 
implied a negative asthma status, the subject’s review was negative (n=60).  If asthma 
was suggested (n=41), the relevant document snippets were copied to a temporary 
spreadsheet, carefully excluding any protected health information as snippets were 
transferred.  The asthma-related search terms followed by the medical assessment search 
terms were used as needed to include as definitive an asthma picture as possible.  These 
de-identified case abstracts were shared with one asthma medical expert.  He labeled each 
one as definite or probable asthma versus negative or unlikely asthma versus asthma by 
history only.  The criteria used to decide a probable asthma status are shown in Table 5.5.  
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 In this dissertation, the purposes and design of the framework were presented.  
The framework was evaluated on two diseases.  The framework-generated rules to 
identify diabetes were similar to the rules generated by domain experts but also added 
useful knowledge to refine them.  Rules to identify asthma added to the sensitivity of a 
validated algorithm based on ICD-9-CM codes.  The framework required no domain 
knowledge to find these patterns.  The machine-learned patterns quantified specific EHR 
data uniquely associated with a disease.  This knowledge is best used in conjunction with 
the specialized knowledge of domain experts to refine and strengthen the identification of 
cases. 
 Observations that have not been identified by experts in existing disease-
identification algorithms were exposed.  In the diabetes identification rules, capillary 
blood glucose testing by glucometers was performed more often, was abnormal more 
often, and served as a better observation type to identify patients with diabetes in the EHR 
than glucose measured in venous blood in a clinical laboratory.  Laboratory-based 
glucose values are the standard for diagnosis of diabetes, have been proven more accurate 
than glucometer results,1 and consequently were specified as one of the criteria to identify 
diabetes in the expert-based algorithms reviewed.  
  
134
 There are many potential predictive combinations in the EHR data.  Combinations 
of attributes are rarely seen in expert-generated algorithms.  There were many 
combinations with the bronchodilator, albuterol, in the asthma rules.  This was because 
albuterol was a frequent and associated medication, but it was not strong enough alone to 
form an accurate rule.  Albuterol is used for other bronchopulmonary problems.  
Albuterol and an inhaled glucocorticoid are found together in expert-generated rules to 
identify asthma.  However, albuterol and female gender was a novel combination, even 
though it was known that more women than men are seen for adult asthma. 
 The rules may refine the observations within categories.  For example, instead of 
a list of all antihyperglycemic drugs, the rules identified specific chemical/ therapeutic 
classes as separate rules.  Some were stronger than others.  Insulin was very strong.  
Metformin was not strong enough to form a single-attribute rule.  It was known that 
Metformin can have false positives, yet there are algorithms to identify diabetes that 
include all antihyperglycemic medications.  Since treatments constantly change, the 
framework process was useful in identifying exactly which medications were in common 
usage during the time period of interest.  In fact, it identified them so well it picked up a 
decreased frequency from one year to the next when a particular diabetes drug was the 
subject of an FDA warning for potential adverse events.  
 There were three assumptions underlying the design for the cohort amplification 
framework, and all three were validated in this work: 
• Patterns learned from exemplars drawn from known cases may be used to 
identify other unknown cases.  Some bias must be anticipated since the known 
cases were identified in some manner, and others were not.  In this 
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dissertation, the proof of concept was demonstrated by other asthma cases 
identified from known cases from the coded Problem List in the electronic 
health record. 
• Knowledge discovery methods over a common set of EHR data could expose 
patterns for multiple diseases and conditions.  A highly abstracted set of 
candidate EHR data, modeled on the derived data types used in some existing 
disease identification algorithms2-4 and drawn from the standard data 
categories required for certification of an EHR, was shown to generate rules 
consistent with disease-specific processes of care. 
• The transaction records of medical care process and documentation could 
provide patterns from the data in the EHR that may be used to identify 
particular disease cases.  Patterns or rules learned by the computer from the 
candidate EHR data used were shown to identify unseen cases of asthma in 
the EHR. 
 The framework classification rules can be analyzed for other purposes.  They do 
not have to be applied in prediction.  Interesting trends were seen in the rules when 
comparison groups were created, such as two different clinical specialties.  There were 
aggregate differences in the choice of medications.  It could be seen that practice patterns 
were different. 
 Finally, the rules may expose interesting associations that were not expected.  The 
main objective of this work was to apply database knowledge discovery methods to 
generate classification rules.  Comorbidities were found among the asthma cases 
identified by the framework rules that were not described in the clinical literature.  Their 
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physiologic connection had been described.  The associations were with other 
inflammatory diseases of the joints and other connective tissue. 
 
Why Associative Classification? 
 Associative classification (AC) has not been widely used in health care data.   
Association rule mining (ARM) was reported more often in the health care literature.  In 
Chapter 2, some examples of health care applications of AC and ARM were presented.  It 
was pointed out that the use of these approaches is growing, as are machine learning 
methods in general, in health care data.  Association mining was developed for retail 
sales problems and has been informally called market basket analysis.  It is widely used 
for business purposes and has continued research, development and improvement as 
reported mainly in the computer science literature.  ARM was developed to find patterns 
among broad and inter-related transaction data, directly from databases without domain 
expertise.  
 At the onset of this research, various classification methods were investigated.  
Associative classification accommodated the broad but sparse data best.  Many other 
methods could not process data with so many missing values.  In the framework, missing 
values were considered unpopulated EHR observations and participated in patterns by 
their absence.  Naïve Bayes accepted the sparse data but was not able to predict as 
accurately as AC.  This assessment was based on raw results from WEKA prior to the 
improvement of accuracy developed in the framework.  Rule-learners, such as Ripper,5 
found similar rules but were not transparent nor popularly used and studied like AC.  
ARM, as implemented in WEKA, provided the interim metrics of the Apriori algorithm.  
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This enabled access to the ARM frequent item sets from which downstream pruning, 
testing and knowledge discovery were accomplished.   
 
Contributions to Associative Classification Methods 
 Ranking and pruning methods were introduced to improve the generality of the 
rules as generated using classic ranking and pruning methods.  These methods not only 
improved the generality but also the accuracy of the rules. There was a serendipitous 
benefit in these methods, which used a final frequency sort, to reduce the final rule set to 
the highest concept level of attributes participating in multiple concept levels. 
 The framework used balanced sample sizes.  This enabled interestingness metrics 
that discriminated the data characteristics of the disease exemplars no matter what their 
prevalence in the EHR.  These were normalized metrics used to focus the rules to identify 
one class only.  By design, one set of exemplars represented a disease or condition of 
interest.  The other represented controls without the condition.  Since the goal was to 
generate rules to identify cases with the condition, it was practical to leverage one-class 
rules.  The evaluation of the merit of the rules was based on sensitivity and specificity.  
Sensitivity and specificity are not affected by prevalence. 
 
Significance to Biomedical Informatics 
 The development and validation of the framework are significant in the field of 
biomedical informatics because they demonstrate a successful application of machine 
learning in the electronic health record.  Development of the framework included 
modification of associative classification methods to address the unique data content in 
the EHR.  Data mining methods have not been applied to their potential in the EHR.  This 
  
138
work suggested that standard methods developed for other industries might need to be 
optimized for the health care data environment.  Further, the methods support high-
throughput phenotypic cohort identification for genomic research.  The framework does 
not generate definitive phenotyping algorithms but exposes and quantifies generalized 
EHR data toward that purpose. 
 
Opportunities for Further Research 
 The framework should be evaluated in other diseases and EHR settings.  Diabetes 
and asthma are well characterized as medical diagnoses, with standard diagnostic and 
treatment patterns.  The current research was conducted in a health care delivery 
environment with mature EHR systems and programmatic efforts to train and support 
providers to use the EHR.  Care documentation for diabetes and asthma was also focused 
on in recent years for institutional clinical quality improvement goals.  Evaluation of 
classifiers for medical conditions where standards of care are not well defined would 
further test the contributions of the framework.  It would also be useful to test the 
reliability of rules for diabetes and asthma in other health care settings.  Are the rules 
overfit to the care setting or more general across settings?  Is there value in seeking rules 
that generalize across settings or is it reasonable to use rules suited to each setting? 
 The framework exposes the frequency and strength of associations among EHR 
data elements to build the classifiers, so the differences in raw data among settings can be 
explored.   It can be applied to the problem of testing differences between settings, 
provider groups or time periods.  A study is underway to test differences in EHR 
observations between two large provider organizations, using the framework to identify 
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observations associated with type 2 diabetes mellitus as a step in attribute selection for 
further statistical analysis.   
 The framework approach can be extended to attributes from other databases, 
including population and behavior data that may or may not be linked to EHR data.  In 
addition, the broad and highly abstract view of EHR data used in this research can be 
focused for particular medical conditions, including data that are more detailed.  
Association rule mining was called a “brute force” method of knowledge discovery 
because it discovers all associations in the attributes presented, then applies various 
metrics and operator-provided thresholds to measure and select the interesting ones.  
Therefore, it provides an opportunity to explore very general problem domains.   
Interesting associations may be refined and constrained to particular focus areas using 
these methods.  The approach can also be used with other knowledge discovery methods 
that model relations that are more complex but usually require a more focused problem 
domain.   
 This research demonstrated success of a high throughput, generalized approach to 
learn classifiers for two medical conditions from the EHR data of exemplars of those 
conditions.  Its potential application to identify, or amplify, health related cohorts was 
posed as an improvement in the efficiency of conducting biomedical research.  These 
methods can also be applied to improve identification of cases for chronic disease 
registries.  Registries support care management activities as well as health services 
research toward improved health care delivery and patient outcomes.  The cohort 
amplification rules are well suited to this task in theory.  Specificity and sensitivity are 
acceptance thresholds set in the rules generation process.  This enables a range of 
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potential accuracy.  In the population of registries, cases may be identified on a scale of 
uncertainty.  Future research includes the development and evaluation of the framework 
for this purpose. 
 
Limitations of this Research 
 
 Existence/nonexistence of EHR observations over an arbitrary time period was 
the data type of all candidate data used in the framework.  This gave a broad but shallow 
pattern search.  This was intended as a first look at patterns for exemplar conditions, 
given data that are generally populated in the EHR.  The intent was to apply the 
framework to better understand the data content as well as to find useful patterns in this 
superficial view.  With a better understanding of actual patterns in stored data for 
particular conditions, a deeper, condition-specific data set might be designed for further 
machine learning approaches.  Useful patterns for disease case identification were found 
in the two conditions studied in this work, diabetes and asthma.  In other conditions, the 
shallow data patterns may not. 
 Administrative codes (ICD-9-CM and CPT) were used in the framework.  There 
are known problems with their reliability and validity as addressed in Chapter 1.  At this 
time, the administrative codes in the EHR are the most comprehensive disease 
documentation available.  The ICD-9-CM codes for the target conditions were removed 
from the candidate data because they would have dominated the rules.  They were used to 
associate comorbidities.  In the short term, while ICD-9-CM codes are widely used for 
cohort identification, the framework rules may augment or validate these algorithms with 
additional rules.  As better data become available, for example by use of NLP to extract 
coded clinical data, the candidate data for the framework can be modified.  
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 The query to gather EHR data can be streamlined to better automate the current 
process.  The current process generated attributes that had to be manually removed.  Most 
of the superfluous attributes were administrative in nature, redundant or simply useless to 
the problem at hand.  An example of the latter is common medical specialties visited 
frequently by all patients.  This is to be expected when mining patterns directly from a 
transaction database.  The least number of candidate attributes is best since computer 
memory consumption is large for Apriori rule mining. 
 A minimum of one thousand training records from disease and control exemplars 
was necessary to find reliable patterns.  This number of exemplars may be difficult to 
find.  If patterns were proven reliable across institutions, training data could be shared for 
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